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ABSTRACT 
One of the recent applications of absorbable biomaterials is in the growing 
field of tissue engineering. The objective of this study is to study the effect of 
the internal geometry of the porous scaffolds on the cell distribution. The 
three-dimensional distribution of cells gr~~tly affects the outcome of tissue 
engineering. A basic requirement involves a scaffold conductive to cell 
seeding and maintenance of cell function. To design scaffolds in this study, 
synthetic polymer, PLGA, was used to provide mechanical strength, Bioactive 
Inorganic Element (BIE) was included to stimulate osteogenesis and salt 
(NaCl) was used to create pores. Two groups of channeled and non-
11 
channeled porous scaffolds of PLGA/BIE, 10 mm in width and 12 mm in 
length, were fabricated by melt molding/particulate leaching. In channeled 
scaffold 6 peripheral channels and one central channel was placed. Each 
peripheral channel was placed 2.5 mm from the border of the scaffold, and 2.5 
mm from the central channel, and 2 mm from the adjacent channel. Normal 
human osteoblasts were extracted from the alveolar bone of young healthy 
adults, and expanded to the second passage. Cells were cultured, stained with 
Neutral Red, and seeded onto scaffold at a concentration of 1.5x 104 
cells/cm 2. Scaffolds were fixed with formaldehyde, paraffin molded and 
sectioned. Sections were studied under the light microscope to evaluate the 
depth of the cell distribution. Results revealed that at p-value of 7x10 -a there 
was more depth of distribution of bone cells in channeled scaffolds compared 
to the control group. 
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INTRODUCTION 
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Introduction: 
The newly emerging field of tissue engineering is a multidisciplinary field 
integrated with the development of natural biological surrogates that restore, 
maintain , or improve upon tissue structure or function . It uses tissue-specific 
cells in a three-dimensional organization provided by scaffolding material , to gain 
back the functionality of the organ (Mikos et al. , 2000) . Tissue engineering 
techniques have been applied to all tissue types , and there has been significant 
progress particularly in the area of bone regeneration (Murphy et al., 1999). 
Bone loss can be due to injuries, genetic malformations , or diseases and often 
necessitates implantation of grafts. Most currently used grafting materials are: 
autografts, allografts, and synthetic materials. Although autogenous bone is 
known as the "gold standard" , its supply is limited and requires traumatic 
harvesting procedures (Schulz RC., 1988). Allogenous bone is genetically limited 
by the risk of transmission of disease and/or rejection , while synthetic materials 
are limited by osteolysis and inflammatory reactions (Tomford et al., 1983) . 
Three general strategies have emerged for tissue engineering. The first is a 
conductive appr6ach in which synthetic scaffold materials are implanted into a 
site of damage where they only allow conduction of the desired cell types and 
block the conduction of unwanted ones. The second approach uses the inclusion 
of bioactive factors such as growth factor into the synthetic scaffolds. The third 
approach is based on the cell seeding of the scaffolds in vitro, followed by 
implantation of the cell construct (Murphy et al., 1999). The need for an alternate 
mammalian tissue source becomes more evident considering the shortage of 
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donor organs and the expenses, as well as probable complications of transplant 
surgery. Absorbable polymeric biomateri~ls play a crucial role in tissue 
engineering, as scaffolds to support cells and as carriers of growth factors to 
allow their controlled release (Kang et al., 1999). 
The choice of the scaffolding material is crucial to the success of the technique of 
bone tissue engineering . The scaffolding material should be osteoconductive, 
biocompatible and biodegradable into noncytotoxic products. Proper physical 
properties of the material, which play an important role in creating the internal 
geometry of the scaffold, are essential. Some of these criteria are high surface 
area/volume ratio, mechanical and structural integrity, and vascular and neural 
infiltration (Putnam et al., 1996). The basic requirement in fabricating scaffolds is 
to use polymers that can create adequate space for cell distribution. High 
porosity is critical in order to provide adequate space and surface for cell 
distribution into the temporary scaffold prior to implantation. Also, this porous 
scaffold shoulo advance the vascularization-of the developing tissue and should 
I 
not interfere with the diffusion of the seeded ,cells into the surrounding tissue after 
its implantation. Once implanted, the polymer should be completely degraded as 
natural tissue forms, since it is only temporarily needed (Kang et al., 1999). 
The most widely used degradable polymers are the polylactic acid (PLA), 
polyglycolic acid (PLGA), PLA-PLGA copolymers, polydioxanone, 
polycaprolactone, and polyorthoesthers to · name a few. PLA, PGA, and their 
3 
copolymers are among the most popular synthetic degradable polymers used as 
implants (Gilding et al., 1981 ). 
Poly (DL-lactic-co-glycolic acid) (PLGA) offers distinct advantages including 
sterilizability and relative biocompatibility have been well documented. Their 
degradation rates can be tailored to match rates of new tissue formation 
(Thomson et al., 1995). 
Bioactive glass, a ceramic graft synthetic material, has shown evidence of 
successful outcomes in promoting osteogenesis. Studies demonstrate bone 
formation directly on the bioactive glass graft material (Hench LL, 1994). This 
I 
ability has been tested and Wilson et al. proved their clinical application in 1994 
(Wilson et al., 1994). 
The PLGA / Bioactive Inorganic Elements (BIE) were used to fabricate porous 
composites. Two groups of scaffolds were constructed. One group contained 
channels while another group did not. Human osteoblast cell lines were cultured 
and dynamically seeded on the channeled and non-channeled, porous scaffolds. 
The generation of de novo bone formation was compared between channeled 
I 
and non-channeled scaffolds by measuring the depth of distribution of bone cells 
stained with Neutral Red. The main objective of this study was to investigate the 
role of 3-D Scaffold geometry on the depth of distribution of cells. 
4 
LITERATURE REVIEW 
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Basics of Bone Formation 
Bone is composed of two elements . The first component is a group of specialized 
cells including mesenchymal and hematopoietic stem-cell lines. The second 
element of bone is the extracellular matrix (ECM). Osteoblasts are derived from a 
mesenchymal origin whereas monocytes and osteoclasts have a hematopoietic 
origin. Although these cells take up a very small portion of the total bone volume, 
they perform critical roles in generation and regulation of the mineralized matrix. 
The main components of the ECM are collagen and an inorganic mineral phase, 
like apatite or hydroxyapatite. Type I collagen, the most abundant collagen in 
bone, occupies 90% of the total organic matrix (Buckwalter et al., 1996a). 
Osteoblasts develop from preosteoblasts, mature through proliferation and 
differentiation and finally become osteocytes (Nijweide et al., 1986; Marks & 
Popoff, 1988). The most evident function of the osteoblast is the synthesis of the 
organic matrix of bone. Products of osteoblasts include type I collagen, 
osteocalcin (Hauschka et al., 1989), osteopontin, and bone sialoprotein (Sodek 
et al., 1987). Osteoblasts are in cubical form in vivo, and are separated from the 
mineralized matrix by an osteoid. Extracellular matrix is secreted only on one 
side of the cell layer. During synthesis of new matrix, osteoblasts contain 
abundant endoplasmic reticulum, golgi membranes, and mitochondria. 
Meanwhil e , th~ ce lls on th ~ bone surface are embedded in the mineralized matrix 
and become osteocytes. These immovable osteocytes are embedded in the 
mineralized matrix and communicate through intercellular gap junctions and 
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cytoplasmic extensions (Sodek et al., 1987). Growth factors and steroid 
hormones play important roles in mediating gene expressions associated with 
osteoblast proliferation and differentiation. Some examples of these factors 
would be fibroblast growth factor, insulin-like growth factor, transforming growth 
factors , platelet-derived growth factor, parathyroid hormone, thyroxin, estrogen, 
testosterone, vitamin D, cortisol , calcitonin, and insulin (Christenson RH, 1997). 
The osteoblast development process takes place in four steps: 
1- The preconfluent proliferation stage ·is where synthesis and intracellular 
pro I iteration of type I collagen are activated and the osteoblast cell 
population is enlarged. Several genes that are associated with the 
formation of the extracellular matrix become actively expressed and then 
are gradually down regulated. Finally, during the subsequent stages of 
osteoblast differentiation, the level of collagen m-RNA is maintained at a 
low basal level. 
2- The postconfluent stage is where there is active expression of the genes 
associated with the maturation and organization of bone extracellular 
matrix (ECM). This results in a 10 fold or more increase in the activities of 
proteins related to osteogenic phenotype (e.g. alkaline phosphatase) and 
their mRNA. During this immediate post proliferative period, the ECM gets 
prepared for the next step, the mineralization stage, by undergoing a 
series of modifications in content and alignment. 
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3- In this step, gene expression directs the sequential deposition of 
hydroxyapatite. Osteopontin and osteocalcin show maximal expression at 
this stage. All cells become alkaline phosphatase positive as the cultures 
progress into the mineralization stage. However, in heavily mineralized 
cultures smaller levels of alkaline phosphatase and its mRNA are evident, 
and collagenase gene is up regulated to a maximum level (Shalhub V, 
1992). As mineralization starts, other bone related proteins such as 
sialoprotein, osteocalcin, and osteopontin are induced or increased. The 
amounts of these proteins are respo~ding to the accumulation of minerals 
(Owen et al., 1990). During the period of active proliferation, osteopontin 
is expressed (at 25% of maximal levels), and is down-regulated after 
proliferation. However, the peak expression of osteopontin will be during 
mineralization. Despite_ osteopontin, osteocalcin is expressed only post-
proliferatively with the onset of nodule formation (Lian et al., 1978). 
4- The fourth step is the maturation of cultures. There is increased 
collagenase, elevated type I collagGr, gene expression, apoptic activities 
and compensatory proliferation activity (Stein et al. 1996). 
Extracellular matrix (ECM), the main element of bone, is composed of collagen, 
I 
elastin, proteoglycans, structural glycoproteins, and an inorganic mineral 
structure. Organization of the ECM has a very important role in shape, 
metabolism, and so many other properties of the cells. This is due to the fact that 
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cells interact with their own ECM products, as well as with the ECM produced by 
other cells (Hay ED. 1991 ). 
As ECM goes through degradation, bone is deposited into large quantities of 
collagen and other matrix components. Bone remodeling, a constant process in 
adults, follows the degradation. The dynan:iir. equilibrium of the bone matrix is 
regulated by several hormonal stimuli such as parathyroid hormone and 
calcitonin (Huffer W, 1988). Two main, cell populations responsible for 
maintaining this equilibrium in adults are osteoblasts and osteoclasts. 
Osteoblasts are capable of matrix fibrillogenesis, while osteoclasts, which 
I 
originate::d from macrophage lineage, act in bone resorption with osteoblast 
assistance. Stimulation of osteoblasts by 1,25-vitamin 03 results in degraded 
collagen films. In the absence of serum, Vit-D3 has no affect in degradation 
I 
(Thomson et al., 1989). The two main routes of bone development are 
· endochondral ossification and intramembranous ossification. In endochondral 
ossification, which happens in organs such· as long bones and the mandible, a 
I 
cartilage template is developed from a mesenchymal analog. Within the 
periodontium the periosteum is laid down , around the center of the cartilage 
model by the process of intramembranous ossification. Osteoblasts and other 
precursors (e.g. fibroblasts) invade the periosteum, pass through layers of 
connective tissue, and invade the hypertrophic cartilage in the reactive center of 
the cartilage model. 
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Incoming cells and osteoblasts degrade the calcified cartilage template by 
synthesizing and depositing bone. The wave of ossification proceeds bi-
directionally outwards and generates a distinctive pattern of zones of resting, 
growing and hypertrophic cartilage in advance of the ossifying tissue. Another 
wave of invasion by hematopoietic cells removes the core of the newly 
synthesized bone in order to generate a hollow marrow , wh ich is populated by 
the developing hematopoietic lineage (Alexander CM & Werb Z, 1991 ). 
lntramembranous bone , such as calvaria, is laid down within a fibrous layer of 
connective tissue. This process is not associated with the massive resorption 
and replacement that is typically seen in endochondral bone formation. 
A functional relationship exists between proliferation and synthesis of ECM. 
Maturation and organization of the ECM leads to the shutdown of proliferation. 
ECM promotes expression of genes that make the matrix competent for 
mineralization and causes full expression of the mature osteoblast phenotype 
(Owen et al., 1990; Stein et al. , 1993). 
Osteoblast Culture Tec hn·q e 
Bone formation can be replicated under experimental conditions. Several 
methods have been deve loped to estab lish osteoblasts in culture. Osteoblast-like 
cells of animals have been frequently used as an economical and convenient 
source. However, findings from animal cell lines may not always be extrapolated 
to humans. Human osteosarcoma cells are often used to explore the function of 
osteoblasts, however these cells have abnormal responses to osteotropic 
agents. Human osteoblasts from trabecular bone of donors were the first 
successfully cultured well-differentiated cell lines (Aufmkolk et al., 1985). The 
technique used to isolate and culture bone cells should be useful in releasing 
cells from the matrix as well as facilitating the separation of osteoblastic cells. 
There are three types of harvest with osteoblast cell lines: mechanical, 
enzymatic, and explant procedures (Sodek et al., 1987). 
The mechanical method isolates osteoblasts from newborn mouse calvaria 
without the use of digestive enzymes. The r:iethod is based on the ability of the 
osteoblasts to migrate from bone onto small glass fragments. Generally, in order 
to obtain enough cells for culture it is essential to use tumor or neonatal/fetal 
· material (Ecarot-Charrier B., 1983). 
The enzymatic isolation method is modified from a technique used by LG Rao et 
al. who used a bacterial collagenase-rich protease mixture to release cells from 
l 
the bone surface. Robey et al. (1985) performed this method on normal human 
bone. In this method, bone is placed in a se·rum containing nutrient medium at 
4° C and it can be used up to 24 hours. The trabecular bone is exposed. Then 
the bone is scraped and minced. Washing with PBS follows this in order to 
cleanse the clinging marrow and blood ·components. The bone chips are 
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incubated for two hours with an enzyme cocktail containing 1 mg/ml of crude 
collagenase, at 37° C on a rotator. The supernatant , which contains the 
collagenase-released cells is removed and mixed with a medium containing 20% 
heat-inactivated fetal bovine serum , cent rifuged and placed into 35 mm-dishes at 
low density . The medium used contains 1: 1 Dulbecco 's Modified Eagle's Medium 
and Ham's formula 12 with 20% heat inactivated fetal bovine serum, 100 units/ml 
of penicillin , with the addition of 100 µg/ml streptomycin sulfate , 5 µg/ml each of 
insulin, transferrin , and selenium . Using this method, osteoclasts release the 
fibroblast cells in the outer layer first , followed by release of the osteoblasts by 
the collagenase treatment at the later stage (Sodek et al., 1987) 
The explant procedure relies on the ability of the bone cells growing out from 
bone explants to retain their osteoblastic properties on subsequent culture. 
Trabecular fragments collected from a biopsy or surgery were washed in 
Phosphate-Buffered Saline (PBS). Bone fragments were dissected to particles of 
3-5 mm. 0.2-0.6 g of bone was placed in 90 mm culture dishes. They were 
treated with bacterial collagenase to remove fibroblastic cells and 
undifferentiated osteoblastic cells. Then they were cultured at 37° C in 95% air, 
5% CO2 with 5-10 ml a-MEM supplemented with 10% FBS containing 50 U/ml 
penicillin , 15 µg/ml streptomycin, and 2 mM glutamine. Medium was changed in 
24 hours and subsequently every 5 days. Outgrowth of cells from bone 
fragments appeared in one week , and in 3-4 weeks a confluent monolayer 
developed. At this stage , the bone explants were removed by adding 5 ml of 
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0.01 % w/v trypsin citrate-saline to trypsinize the confluent cells. The cells will 
detach when agitated for 5 minutes at 37° C. By addition of an equal volume of 
medium supplemented with 10% FBS the trypsinization will. stop. Cells were 
collected at 400g by centrifugation, washed with the above medium, and plated 
into 35-mm tissue culture dishes at 5x104 cells/dish (Sodek et al., 1995). The first 
passages of the cells from various types of bone express alkaline phosphatase 
activity, respond to parathyroid hormone, and synthesize high levels of collagen 
and osteocalcin. These productions are regulated by 1,25 (OH)2 D3 . The age of 
the patient determi nes the time to reach confluency. Studies show that human 
osteoblasts maintain the phenotype at least through two passages (Eriksen et al., 
198~; Harris et al., 1995). 
13 
Scaffold Architecture 
Scaffold 
A scaffold is defined as a transitional physiochemical structure within which cells 
occupying it form a replacement tissue as the prosthesis disappears or becomes 
integrated into the surrounding tissue. An ideal bone substitute would simulate 
an autograft but eliminate the associated problems and restrictions. The choice 
of scaffolding material has significant impact on the outcome of an osteoblast 
transplantation approach. The ideal scaffold should (Feinberg et al. , 2000): 
~) show cell attachment and should be able to be remodeled by the cells. 
b) be biodegradable and nontoxic with degradation products that are 
nontoxic. 
c) posses the same strength , compliance and density as the tissue it's 
replacing. 
d) allow cell motility and ingress of vascular elements. 
e) have a low level of immunogenicity and thrombogenicity. 
f) have interaction with its surrounding tissues. 
Scaffolds have been categorized into three classes (Feinberg et al., 2000): 
1- Non-bioabsorbable class, which fabricated of man-made materials , such 
as Dacron, Nylon and PTFE (polytetrafluroethylen), which contain little or 
no information for cells 
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2- Bioabsorbable class , composed of the man-made materials with low 
information for cells such as polylactic acid (PLA), polyglycolic acid (PGA) , 
combinations of PLA/PGA, and calcium phosphates ceramics 
[hydroxyapatite (HA) , tricalcium phosphates (TCP)]. 
3- Naturally occurring materials that contain high information for cells such as 
secreted biomatrix, animal and human tissues or animal polymers . 
When utilized to develop tissue substitutes, the tissue engineering approach 
concentrates on the importance of the structural design of the biomaterial 
employed as scaffolding architecture , and emphasizes optimizing structural and 
nut! itional conditions. The architecture is ever more believed to add considerably 
to the development of specific biological function in tissues and it is intended to 
supply proper nutritional environments and spatial organization for cells. In 
designing scaffolds to specifically meet survival and replication conditions of the 
cellular composites, surface biocompatibility as well as structural biocompatibility 
should be taken into the consideration (Wintermantel et al., 1996). 
In designing the structure of the scaffolds , structural elements such as pores can 
form a more complex architect ure. These structural elements maintain the 
structural in e rity of the caffo ld. The coherence of these elements establishes 
the mechanical properties, distribution of open porosity, and the order of cells 
that utilize this superstructure as a scaffold. 
15 
Bone tissue engineering uses different natural and synthetic materials in 
fabricating scaffolds. This selection has been mainly based on biocompatibility , 
biodegradation, mechanical strength , bioactivity and the morphology of the 
scaffold . For the past four decades, bioceramics have played an important role 
as bony graft materials in repair, reconstruction, and replacement of diseased or 
damaged parts of the body . 
Bioceramics 
Bioceramics are 'classified into four groups based on their tissue attachment 
behavior (Hench LL, 1998): 
- The first group includes alumina (AbO3) and zirconia (ZrO2). They 
are bio-inert and are utilized in the repair of bone defect s by bone 
growth into surface irregularities. These materials need cement or 
pressure for bonding, or need to be press fitted into the defect. The 
use of AbO 3 in orthopedic surgery for total hip replacement was 
started more than 20 years ago. The wear rate depends largely on 
the size of the grains. If the grains are small (<4 µm), the wear rate 
is slow , which results in a narrow size distribution whereas if large 
grains are present the wear is very rapid. 
- The second group is porous implants , composed of porous 
hydroxyapatite (HA) and HA coated porous metals. They attach 
mechanically by bony ingrowth into the porous material. 
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- The third group is the resorbable materials , including tricalcium 
phosphate , calcium sulfate (plaster of Paris) , and calcium 
phosphate salts. They work in bulk or powder form, can attach to 
bone and get slowly replaced by bone. 
The fourth group is the surface reactive ceramics , composed of 
dense hydroxyapatite , bioactive glasses , and glass ceramics . Their 
mechanism of action is to attach directly to bone by chemical 
binding. 
Bioactive glasses 
Bioactive glass is a surface reactive biomaterial with a very specific biological 
response at the interface of the material. It bonds between the bone tissue and 
the implant using physiochemical bonds without formation of · a fibrous capsule. 
A certain compositional range of the material is necessary to achieve its bonding 
to bone. This surface bioactive material was developed by addition of P2O5 to 
Na2O, SiO2, and CaO. Compositions with high CaO:P2O3 , high Na2O and Cao 
content, and < 60 molo/o SiO2 such as 45% SiO2, 24.5% Cao, 24.5% Na2O and 
6% P2Os, increase the surface reactivity (Hench LL, 1994). Experiments showed 
that this material is biocompatible and nontoxic (Wilson J , 1981). It neither 
causes inflammation nor prevents cell divis ion and growth in culture. 
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This bioactive material is divided into two classes: 
- Class A has osteoproductive activity due to both intracellular and 
extracellular factors. Osteoproduction is defined as "The process 
whereby a bioactive surface is colonized by osteogenic stem cells 
free in the defect environment as a result of surgical intervention" 
(Wilson et al., 1992). Material elicits both an intracellular and 
exteracellular effect on bone proliferation. The intracellular effect is 
a result of silicon release and is derived from the important role of 
soluble silicon on bone growth , whereas the exteracellular effect is 
due to chemisorption of bone growth proteins, such as TGF-~ 1, on 
the implant surface. Following exposure of the bioactive glass to 
body fluid, soluble silicon is released by both ion exchange and 
network dissolution. This continues until a solubility limit is reached, 
which depends on the pH and the concentration of the other 
species in solution. This can lead to the precipitation of a complex 
silicate phase . The extracellular effect is a result of high surface 
area. Class A bioactive materials form hydrated silica gel and a 
hydroxycarbonate apatite (HCA) layer, which results in nanometer 
scale porosity. This silica-gel layer usually is formed within minutes 
of being exposed to body fluids (Hench LL, 1994). 
- Class B is osteoconductive, where the implant provides a 
biocompatible interface along with bone margins. Bioactivity occurs 
where an extracellular response is elicited at its interface. This 
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class possesses low or zero rates of ion exchange with low rates of 
network dissolution. It releases insignificant or zero amounts of 
soluble silicon (Hench LL, 1994). 
There are 12 stages of interfacial reactions involved in forming a bond between 
tissue and bioactive glass. Bioactive glasses form SiOH bonds and release 
Si(OH)4 after contact with tissue fluid. Si(OH) 4 is polycondensated to form 
hydrated silica gel. Amorphous Ca2+, Po/-, and co/- are assimilated to 
crystallize hydroxyapatite (HCA). The HCA layer absorbs biologica l moieties , and 
following this, macrophages start their action. Osteoblast stem cells attach to the 
HCA layer , differentiate to osteoblasts, and proliferate to generate a matrix 
(Hench LL, 1996). It has been proposed that following exposure to body fluid , 
soluble silica released from this material is repositioned as a silica gel layer. This 
is followed by deposition of a layer of calcium phosphate on this porous silica gel 
surface , forming a hydroxycarbonate apatite layer, where the final bone 
deposition and crystallization occurs . Rapid ionic exchange occurs on the surface 
ofthe Bioglass in 5 stages . Stage one is controlled by ion exchange. It starts with 
rapid exchange of Na+ or K+ with H+ or H3O- from the solution. 
Si-O-Na+ + H+ +OH- ➔ Si-OH+ Na+ (solution)+OH -
Stage 2 is controlled by an interfacial reaction. Following the break of Si-O-Si 
bonds , the soluble S.iO2 from Si(OH)4 goes into the solution resulting in the 
formation of Si-OH (silanols) at the glass solution interface. 
Si-O-Si + H2O ➔ Si-OH + OH-Si 
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At stage 3, SiO2 rich layers are condensed and re-polymerized on surfaces 
depleted of alkalis and alkaline-earth cations. In stage 4 , migration of Ca2+ and 
(PO4r 3 groups to the surface through the SiO2- rich layer forms a CaO-P2O5 rich 
film on top of the SiO2 rich layer. This is followed by growth of the amorphous 
CaO-P2Os rich film by incorporation of soluble calcium and phosphates from 
solution. In stage 5, the crystallized amorphous CaO-P2O5 film forms a mixture of 
hydrqxyl , carbonate, and fluoroapatite layers with incorporation of OH-, (CO2) 3- , 
or F- anions from the solution (Hench LL, 1994 ). At stage 6, the increased 
surface area of HCA changes its isoelectric point and provides new binding sites 
for proteins. In stage 7 and 8, macrophages start their action and osteoblast stem 
cells attach to the HCA layer. In stages 9 and 10, soluble Si activates bone stem 
cells to produce growth factors that absorb into the silica gel and HCA layer. 
This leads to rapid proliferation of bone cells. Stages 11 and 12 include 
mineralization of the osteoid at the interface leading to a bond of glass to bone 
(Hench LL, 1996). 
Bioactivity Assoc iated with Biog lass Composition 
An in vitro study showed that there was a relationship between reaction time and 
silicon composition (Filgueiras MR, 1993a). When silicon content was increased 
up to 52-wt¾, the rate of reactions in stages 1-3 was decreased; however, there 
was little effect on stage 4 and 5. If silicon content was 69-wt% , stage 3 (silica re-
polymerization) was greatly retarded and crystallization of the HCA layer 
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formation from the amorphous-calcium phosphate was inhibited. This 
phenomenon confirmed the importance of a Si-rich phase in the rapid 
crystallization of HCA layer. The rate of HCA formation in a simple Tris buffer 
solution has been examined. Bioactive glasses with compositions of <53 mol% 
SiO2 formed an HCA layer within 3 hours and bonded to both hard and soft 
tissues. In the case of bioactive glasses between 53-56 mol % SiO2 content, 2-3 
days was needed to form an HCA layer and their bonding capacity was only to · 
bone, not to soft tissues. Bioactive glasses with > 60 mol% SiO2 content did not 
form a bond with either bone or soft tissue. This finding was challenged by 
Kokubo (1990a). He showed that Tris buffer solution did not produce an HCA 
layer on bone-bonding apatite/wollastonite glass-ceramic. However, exposure of 
apatite/wollastonite glass-ceramics to simulated body fluid that contained ions in 
concentrations similar to those of the human body produced a polycrystalline 
HCA layer. In simulated body fluid, due to the presence of calcium and 
phosphate in this fluid, the repolymerization of a silica- rich layer on the glass 
(stage 3) and formation of an amorphous Ca-P layer (Stage 4) were accelerated 
to a small extent. However, the time for crystallization of the Ca-P layer to HCA 
layer (Stage 5) was decreased. Magnesium might slow down formation of the 
Ca-P and crystallization of HCA layer (Filgueiras MR, 1993b). 
Osteoproduction 
There are numerous in vivo studies that prove this property of bioactive glass. In 
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a study done on monkeys , periodontal defects were filled with bioactive glasses. 
It showed good hemostasis and high osteoproductive abilities of bioactive 
glasses, which allows the restoration of both alveolar bone and periodontal 
ligament (Wilson et al. , 1992). 
In 1994, a study done by Vrouwenvelder et al. compared Bioglass with four other 
bioactive glasses. It showed that a small addition or subtraction of specific ions 
such as iron, titanium , fluorine or boron modified the basic 45S5 Bioglass 
network. The results show that proliferation rate and osteoblastic expression 
lessened in iron-doped cultures and was higher in titanium-doped cultures. A 
compact morphology of the osteoblasts, normal proliferation, and moderate 
osteoblast expression were found on fluorine and boron-doped cultures 
(Vrouwenvelder et al. , 1994). 
Heikkila et al. conducted a study with rabbits in 1995 using Bioglass to fill 
cancellous bone defects. The results revealed that Bioglass treated defects filled 
in earlier compared to the autogenous bone and that the thickness of the reaction 
layer on the glass surface increased from 82 µm to 163 µm during the 
experiment period of 12 weeks (Heikkila et al. , 1995). In 1996, Rust et al. 
evaluated the long-term use of Bioglass for middle ear prostheses and showed 
the long-term biocompatibility of Biog lass in 37 patients (Rust et al., 1996). In 
1997, Stanley et al. filled up the sockets of extracted teeth with Biog lass cones to 
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pres~rve the ridge. They found that at 5 years Bioglass cones have a high 
retention rate (85.7%) (Stanley et al. , 1997). 
Price et al. in 1997, Compared Biog lass, titanium disks , and cobalt chrome alloys 
by seeding MG63 cells on them . Results showed that Bioglass provided a more 
favorable environment for the cells (Pric et al. , 1997) . 
Low et al. conducted a study on 12 patients in 1997 and used Bioglass particles 
to repair periodontal osseous defects. Results showed significant improvement 
and patients were stable in 24 months (Low et al. , 1997). 
In 1997, Oonishi et al. performed a study on rabbits and compared 45S5 
Bioglass with hydroxyapatite as a bone graft substitute in femoral defects. 
Results showed that defects in the femoral condyles of mature rabbits were 
restored completely with bioactive glass in 2 weeks, whereas it needed 12 weeks 
for the .hydroxyapatite treatment (Oonashi et al., 1997). 
In 1997, Wheeler et al. used Bioglass in a rabbit radius osteoctomy and reported 
that bioactive glass contributed to the early stage of the bony defect treatment. 
Bioactive glass displayed active mineralization throughout the osteoctomy. After 
4 weeks the amount of bone filled within Bioglass-filled defects was greater than 
in untreated defects. There was no significant difference between groups at 8 
weeks (Wheeler et al., 1997). 
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In 1998, Froum et al. conducted a comprehensive study using Bioglass particles 
( 
and compared them with open debridement in 59 defects of 16 patients at 3, 6, 
and 9 months periods. Results showed that clinical attachment level was highly 
improved (p=0.0004) in Bioglass sites (2.96 mm) compared with control sites 
(1.54 mm). Also, gingival recession was significantly less in Bioglass sites (1.29 
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mm) compared to control sites (1.87 mm) . Bioglass sites showed significantly 
higher defect fill and depth reduction (3.28 mm, 4.36 mm) compared with control 
areas (1.45 mm, 3.15 mm) (Froum et al. , 1998). 
Sol-gel Bioglass , Perioglass and hydroxyapatite (HA) were implanted in the tibial 
condyles of rabbits for 2 and 8 weeks. Chemical composition of these materials 
is shown in Table-1. Sol-gel Bioglass generated the greatest amount of woven 
bone and cartilage in 2 weeks . This was replaced by dense compact bone at 8 
weeks. Perioglass had a higher level of intramembranous bone than HA. 
Osteocalcin expression was significantly upgraded by sol-gel Bioglass (p<0.01) 
and Perioglass (p<0 .05). ALP was at the same level among all the g·roups. EDS 
analysis revealed that sol-gel Bioglass rapidly released a high level of Si, which 
then diffused into surrounding tissue followed by an increased concentration of 
calcium and phosphate indicating early bone formation (Chou L & AI-Bazie S, 
1998c). 
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Sol-gel Bioglass Perioglass Hydroxyapatite 
Si 60.19 43.98 39.56 
Ca 20 .25 13.07 52.55 
p 10.06 8.55 6.97 
Na 0.36 . 33.04 0.37 
Mg 0.04 1.22 0.21 
K 0.25 0.13 0.34 
Total 100.00 100.00 100.00 
Table-1. Chemical composition of Bioactive glasses by EDS (atomic%) 
Clinical applications of bioactive glasses include a middle ear device and a 
cochlear implant. The middle ear device has been successful up to 10 years 
without rejection due to the ability of Bioglass to bond to the soft tissue of the 
tympanic membrane without a need for bone paste or cartilage (Wilson et al. , 
1994). The cochlear implant must achieve a transcutaneous seal, no infection 
and the ability to both transfer signals and stimulate nerve endings properly. No 
metal or polymer but Bioglass can achieve these requisites (Wilson J, 1981 ). In 
the dental fie ld, this material is used to form endosseous ridge maintenance 
implants for denture stab ility and is widely used for periodontal treatment , sinus 
lifts and pre-prosthodontic treatment as Perioglass , with high success rates 
(Wilson et al. , 1994). 
Yilmaz et al. in 1998 showed that when cone shaped bioactive glasses were 
implanted into the sockets of previous extraction sockets, a significant difference 
between the original ridge height and width (control group) and postoperative 
measurements was seen in 12 months. After 1 year, no dehiscences were 
detected and the height differences remained significant between the groups 
(Yilmaz et al., 1998) . 
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In another experiment, powder mixtures of tetracalcium phosphate (TCP), poly 
(acrylic-co-itaconic) and bioactive glass (up to 50% by weight) were hot pressed 
for 30 minutes at 300° C and 40 kpsi. Study investigated the tensile strengths, 
elastic moduli, and microstructures of the prepared composites. It was revealed 
that addition of bioactive glass enhances the mechanical properties of these 
composites with the highest values of tensile strength and elastic modulus being 
found at 10% bioactive glass (Greish et al., 2000). 
Extraction sockets of 16 patients were filled with bioactive glass coated with a 
layer of calcium sulfate and compared with the control sites. The reentry 
surgeries showed that experimental sites had significantly more bone fill (6.43 ± 
2.78 mm vs. 4.00 ± 2.33 mm on control sites), and less resorption of alveolar 
bone height (0.38 ± 3.18 mm vs. 1.00 ± 2.25 mm on control site). Horizontal 
resorption of the alveolar bony ridge was similar in both groups (3.48 ± 2.68 mm 
vs. 3.06 ± 2.41 mm on control sites) (Camargo et al., 2000). 
The osteogenic potentials of a melt-derived bioactive glass ceramic (Bioglass 
45S5) compared with a bioinert substrate , both seeded with human osteoblasts, 
for periods of 2, 6, and 12 days were examined. Based on flow cytometric 
analysis of the cell cycle , the bioactive glass ceramic substrate induced 
osteoblast proliferation . It was concluded that Bioglass 45S5 has the ability to 
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stimulate the growth and osteogenic differentiation of human primary osteoblasts 
(Xynos et al., 2000 ). 
Bioactive particles-45S5 Bioglass, synthetic hydroxyapatite, and A-W glass 
ceramic were implanted in 6-mm diameter holes drilled in the femoral condyles of 
mature rabbits. Results showed that bone product ion was faster with 45S5 
Bioglass compared to the other two . 45S5 was resorbed more quickly than A-W 
glass-ceramic and synthetic hydroxyapatite was not resorbed at all. The 
resorption process occurred by solution-mediated dissolution producing chemical 
changes in the enclosed particulate. The rate of bone growth correlated with the 
rate of dissolution of silica as the particles resorbed (Oonishi et al. , 2000). 
Bioactive glass S53P4 and autogenous bone were used in an experimental 
rabbit model as bone graft materials for spinal fusion . A mixture of bioactive glass 
and autogenous bone , autogenous bone alone, and bioactive glass alone was 
implanted for periods of 4 and 12 weeks at the thoracolumbar level. During the 
observation period , the autogenous group showed the same measured amount 
of bone level , while glass and glass/autograft groups showed increases in bone 
level. By 12 weeks , all three groups showed no significant difference in bone 
formation (Lindfors et al., 2000). 
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PLGA 
There has been considerable interest in the use of biodegradable polymers for 
the sustained release of protein and peptide drugs. Poly (DL-lactic-co-glycolic 
acid) (PLGA) copolymers are one of the most commonly used polymers since 
they satisfy many of the requirements already discussed. PLGA is a member of 
the thermoplastic aliphatic poly (esters) family [which also includes poly (PLA) 
and poly (glycolide) (PGA)] and possesses many favorable properties such as 
good biocompatibility, biodegradability, and mechanical strength (Jain RA, 2000). 
PGA, PLA and their copolymers are by far the most popular synthetic degradable 
polymers for resorbable drug delivery devices and implants (Gilding et al., 1981 ). 
These materials are used extensively in research settings as well as approved 
therapeutics. PGA and PLA have been used in medical field as biodegradable 
sutures such as Dexon, a commercially available PGA, and Vicryl, which is 
PLGA (Zhang et al., 1993). PLA can be synthesized by a cationic ring 
polymerization of lactide, the cyclic diester of lactic acid. Lactic acid is optically 
active and has an asymmetric carbon, which enables preparation of the PLA in L-
, D-, and racemic DL- forms. L-PLA is crystalline, has a glass transition 
temperature of 50-60° C and a melting point of around 180° C. It is soluble in a 
limited number of solvents such as chloroform and methylene chloride. DL-PLA 
is amorphous, has a glass transition temperature of 50-60° C and is soluble in 
most commonly used organic solvents including acetone, benzene, chloroform, 
dioxane, ethyl acetate, and methylene (Juni et al., 1987). PGA is synthesized in 
a way similar to formation of PLA by ring opening polymerization of glycosides. 
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PGA is crystalline, has a glass transition temperature of 360° C and a melting 
point of 223-227° C. It is insoluble in most organic solvents, however it is soluble 
in hexafluoroisopropanol, phenol-trichlorophenol , and hexafluoroacetone. 
Normal crystallinity of L-PLA and PGA is about 37% to 50% respectively . In a 
copolymer series of L-lactic and glycolic acids, crystallinity decreases linearly 
with the increase of either comonomer. Also, the melting point decreases with an 
increase in either comonomer. L-PLA and PGA represent hydrophilic and 
hydrophobic crystalline mixtures due to their different chemical structure. PLA is 
more hydrophobic than PGA, since a methyl group in PLA replaces one of the 
hydrogen groups in PGA. The higher the hydrophilicity of the copolymer, the 
greater the water uptake and th is will result in higher biodegradation rate (Juni et 
al., 1987). 
In Vitro & In Vivo Studies 
Glycolic acid released from PGA and lactic acid released from PLA can cause 
some inflammatory reactions (Bostman OM, 1991 ). This will impact on 
osteoblastic activity and might inhibit this process (Roberts et al., 1992). 
In 1994 lshaug et al. studied poly (alpha-hydroxyesters) as substrate for 
osteoblast culture and bone regeneration. Rat osteoblasts were cultured on films 
of biodegradable poly (L-lactic acid) (PLLA), 75:25 poly (DL-lactic-co-glycolic 
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acid) (PLGA), 50:50 PLGA , and poly (glycolic acid) (PGA) for up to 14 days. 
Osteoblasts attached equally well to all the polymer substrates after 8 hours in 
culture. By day 4 in culture , osteoblasts had exceeded confluency numbers , and 
their proliferation leveled off by day 7. An increase in alkaline phosphatase 
(ALP) activity from 1.92 (+/- 0.47) x 10(-7) for day 7 to 5.75 (+/- 0.12) x 10(-7) 
mumol/cell per min for day 14 was reported for osteoblasts cultured on 75:25 
PLGA. This was comparable to that observed for tissue culture polystyrene 
(TCPS) controls . The ALP activities expressed by osteoblasts cultured on PLLA , 
50:50 PLGA , and PGA films did not significantly increase over time. Collagen 
synthesis for osteoblasts cultured on all polymer substrates was similar to that of 
TCPS and did not vary with time. The morphology of cultured osteoblasts was 
not affected by the continuous degradation of the polymer substrates. These 
results demonstrate that poly (alpha-hydroxyesters) can provide a suitable 
substrate for osteoblast culture and hold promise in bone regeneration by 
osteoblast tra nsplantation (lshaug et al. , 1994). 
In 1994, Puelacher et al. implanted PLA and PGA scaffolds subcutaneously into 
nude mice with or without chondrocyte pretreatment. After 8 weeks cartilage 
formation was present only in scaffolds that were pretreated with cells (Puelacher 
et al. , 1994c) . 
In 1993, Freed et al. , cultured osteocytes that were isolated from bovine or 
human articular or costal cartilage on fibrous PGA and porous PLA. In vitro , cell 
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growth on PGA produced S-GAG at a high, steady rate and the rate was two 
times higher than PLA. This was attributed to the geometry of the polymer and 
degradation rate (Freed et_ al., 1993). In another study done by Freed in 1998, 
chondrocytes were cultured in PGA and the results showed an increase in the 
amount of glycosaminoglycans (GAG) and type II collagen (Freed et al., 1998). 
Another study showed that the density of PLGA polymer has a significant 
influence on the release rate, and that higher density results in slower release. 
The result of this experiment showed that low molecular weight PLGA releases 
ionized faster than those with a higher crystallinity (Hsu et al., 1997). 
Rat calvaria cells were used in a culture mixture of PLGA and HA in order to 
evaluate their abil ity to maintain their phenotype properties for a period of 24 
days. For the first two weeks ell attachment and proliferation increased and was 
followed by a period of gradual plateauing of cell numbers. No mineralization 
occurred in the cell free mixtures or in the samples without beta-
glycerophosphate. This shows that mineralization is due to cells not the HA 
(Laurencin et al., 1996). 
Fu et al. showed that within the PLGA particles a very acidic environment formed 
with the minimum pH as low as 1.5. Using pH sensitive fluorescent dyes 
(conjugated to 10,000 DA dextrans) and confocal fluorescence microscopy they 
were able to visualize the spatial and temporal distribution of pH within the 
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degrading microspheres. They confirmed a pH gradient where the most acidic 
environment is at the center of spheres and higher pH is near the edge. This is 
characteristic of diffusion-controlled release of acidic degrading products (Fu et 
al., 2000). This study emphasized the fact that acidic monomers generated by 
the degradation of polymers are of concern in the development of these devices 
for drug delivery. 
Total incorporation of recombi nant human bone morphogenetic protein-2 
(rhBMP-2) in microspheres made from PLGA was studied based on molecular 
weight, polydispersity, and the acid number of polymers. The most dominant 
feature affecting the binding was the polymer acid number. Higher acid values 
showed increased rhBMP-2 binding. The amount of non-bound incorporated 
rhBMP-2 linearly correlated with the protein concentration used in binding. 
Higher concentrations of rhBMP-2 inhibit binding to PLGA microspheres. Also, 
increased lactide content in the PLGA polymer inhibits the binding . Binding of 
rhBMP-2 to PLGA microsphres is mostly controlled based on characteristics of 
acid value, followed by molecular weight and lactide/glycolide ratio. The total 
incorporated amount of rhBMP-2 depends on the bound amount and on the 
amount of free protein present (Schrier et al. , 1999). 
In 1998 Gao et al. --~onducted study t show that surface hydrolysis of poly 
(glycolic acid) (PGA) meshes raises the cell seeding density. Ester groups on the 
surface of PGA fibers get transformed into carboxylic acid and hydroxyl groups 
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when hydrolyzed in 1 M NaOH. Following hydrolysis, gross appearance and 
dimensions of the polymer scaffold was retained while the fiber diameter 
decreased in a linear relationship . No change was observed in the molecular 
weight or the thermal properties of the polymer (Gao et al., 1998). 
Another study conducted by Eiselt et al. showed that the ratio of lactic to glycolic 
in the polymer determines the ability of the polymers to resist the compressive · 
forces (Eiselt et al., 1998). 
Research has shown that incorporation of either soluble salt or low molecular 
weight polymeric species modulates the release kinetics of the system. Salt 
promotes modulation without changing the inherent degradation rate of the 
system. This effect can be due to the enhanced amount of swelling and uptake of 
buffer by the films loaded with soluble salt. The uptake may create microscopic 
pores and permit further diffusion of tetracycline from the polymer matrix as well 
as allowing the free monomers to vacate the system (Webber et al., 1998). 
Phase inversion dynamics and in vitro drug release properties of PLGA-based 
drug delivery systems can be affected by formulation changes. Tests show a 
high initial rate using additives that increase the rate of gelation at constant 
morphology. On the other hand, using additives that slow the solution gelation 
rate result in a more dense sponge-like morphology, which dramatically decrease 
the initial drug release rate. Whether the solutions are quenched with water , a 
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PBS buffer solution or horse serum, the phase inversion dynamics and 
morphology are the same (Graham et al., 1999). 
Poly (caprolactone) (PCL), Poly (DL-lactic-co-glycolic acid) (PLGA), and 
combinations of these polymers were tested for their ability to support bone 
marrow stromal cell proliferation and differentiation . Bone marrow stromal cells 
were cultured from New Zealand white rabbits. The results indicated that PCL 
alone is not a satisfactory material for the creation of a bone substitute. 
However, by adding PLGA can create a bone substitute material (Calvert et al. , 
2000). 
Microstructural and mechanical properties of composites composed of calcium 
deficient hydroxyapatite (CDHAp) and poly (lactide-co-glycolide) (PLGA) were 
studied. Compositions of 80:10:10 wt% and 60:20:20 wt% of alpha-TCP-PLGA-
NaCI were studied. After hydrolysis at 37° C, 45° C, and 56° C, Scanning 
Electron Microscopy (SEM) examined the microstructural evolution and variance 
in final composite microstructure . The tensile strength . values of the two 
composites were measured at 37° C. Results showed a variation with hydrolysis 
temperature and composition, which may be due to the fina l microstructure of the 
composites. This microstructure is governed by the morphological changes in the 
polymer structure at its glass transition temperature as well as the extent of 
cement-type formation of CDHAp by hydrolysis of alpha-TCP (Duracan et al. , 
2000). 
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In 2000 , Kostanski et al. conducted a study to evaluate the binding to PLA [Poly 
(D,L-lactide)] and PLGA and non-specific adsorption to blank PLGA by using 
0.1 M phosphate buffer, pH 7.4 (PB) and 0.1 M acetate buffer, pH 4.0 (AB). In 
vitro peptide release was evaluated in both PB and AB. Results showed that 
peptide binding to PLGA and PLA and non-specific adsorption to blank PLGA 
were pH dependent and were notably higher in PB than in AB (Kostanski et al., 
2000). 
By varying the pore wall thickness and pore surface/volume ratio, one can 
engineer the degradation rate of the porous foams. In a study conducted by Lu et 
al. in 2000, four types of PLA foams were fabricated using a solvent casting/ 
particulate leaching technique. The first three types had initial salt weight fraction 
of 70 ,80, and 90% with a particle size of 106-150 µm, and the fourth type had 
90% initial weight fraction of salt in the size range of 0-53 µm. The macroscopic 
degradation of PLA foams was independent of pore morphology with insignificant 
variation in foam weight, thickness, pore distribution, compressive creep 
behav ior, and orpholog y during degradation. · Due to an autocatalytic effect, 
faster foam degradation was seen in the thicker walls of foams prepared with 70 
or 80% salt weight fraction as compared to foams with 90% salt weight fraction. 
The enhanced pore surface/volume ratio of foams prepared with salt in the range 
of 0-53 µm improved the release of degradation products hence diminishing the 
autocatalytic effect and insuring slower foam degradation relative to those with 
salt in the range 106-150 µm. At early stages of degradation, formation and 
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release of crystalline particulates were seen for foams fabricated with 90% salt 
weight fraction (Lu et al., 2000). 
In 2002, Zhang et al. studied the bone regeneration behavior in porous D, L-
polylactic acid (D,L-PLA) with different pore sizes. A particulate-leaching method 
was employed to prepare porous biodegradable D, L-PLA with different pore 
sizes (75, 250, 400, 750 micrometer) and with porosity of 75% as the materials to 
repair bone defects in rabbits. The materials were then implanted at random into 
40 rabbits with bilateral radius bone defect, leaving another 10 rabbits without 
implantation · as blank control. Gross observation and X-ray and 
histomorphological examination as well as assessment of the biomechanics of 
the implants were performed in 2, 4, 8 and 12 weeks respectively after the 
operation. New bone tissue occurred around the implanted materials with pore 
sizes of 250, 400 or 750 µm 12 weeks after the operation. In the control group 
and in the rabbits with implants with pore size of 75 µm, the bone defect was 
filled with connective tissues . The implants with 250 µm pores had the strongest 
biomechanical strengths of all the materials (P<0.01) at 8 weeks and 12 weeks 
after the operation. It was concluded that the pore size of the porous implants 
decides the behavior of bone regeneration, and D, L-PLA polymer with 250 µm 
pores produces the most desired effects (Zhang et al., 2002). 
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Internal Design of Scaffolds 
The literature indicates . that intra-architectural design can affect diffusion 
pathways of nutrients, mechanical compliance , and mechano-transductive forces 
on the invading tissue or implanted cells. The geometry or pore size of a 
biomaterial scaffold carrier plays an important role in the type and amount of 
tissue regeneration (Feinberg et al., 2000). Also , studies show the role of internal 
pore structure in the design of scaffolds. Internal pore structure influences crucial 
factors in tissue generation such as nutrient diffusion , cell and tissue penetration 
and mechanical behavior. Internal architecture must be selected carefully since it 
can greatly influence the matrix deposition (Hollister et al. , 2000). 
A key material requirement in design of scaffold is a large surface area/volume 
ratio to support cell adhesion, and facilitate the transport of cells and nutrition. A 
highly porous scaffold promotes activity of cells by increasing the substrate area 
for growth and proliferation as well as allowing optimal diffusion of nutrients 
among cells in the scaffolds and the surrounding tissues. Macropores are 
intended to allow development of vascular tissue by the ingrowth of granulation 
tissue from the host. Vascularization plays a critical role by expediting mass 
transport, which is sen ia in he regi of a deve loping tissue. Mechanical 
integrity of the scaffold material is crucial for resistance of contractile cellular 
forces, which can result in collapse of the 3-D structure of a scaffold during tissue 
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growth and development. This can entail control of the shape of the final tissue 
product and result in a scaffold system wi h shape memory (Murphy et al., 1999). 
Several studies show that scaffold pore size influences the formation of bone or 
cartilage regeneration. The geometric properties of the carrier, especially the 
length and continuity of pores and the surrounding spaces control capillary 
penetration, and as a result, influence bone formation. 
A carrier that allows capillaries into its interior induces bone formation, whereas 
one that prevents such a penetration induces cartilage formation. Pores must be 
larger than the diameter of active capillaries, which can supply enough blood for 
bone formation. Development of a single capillary should permit osteon-like 
structure formation. A study done by Tsuruga investigated this and showed that 
the diameters of osteons measure from 200-300 µm, central canal diameter 
varies from 20-50 µm, and the wall thickness is up to 80 µm. This study 
considered concave surfaces of ceramics of hydroxyapatite with 300-400 µm 
pore size to be ideal for generation of adequate cell density for osteogenesis. 
Data showed that as the pore size became larger than 300-400 µm, the inner 
wall became thinner and when the pore size increased to 500-600 µm no 
integrated bone formation occurred along the inner walls. In the 400-500 µm and 
500-600 µm pores, multiple large capillaries were found within a single pore. 
This was not observed in the pores of 300-400µm. They suggested that the 300-
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400 µm or ~maller pore size would be most appropriate for haversian osteoid 
formation leading to preferential bone formation (Tsuruga et al., 1997). 
One of the reasons that vasculature is essential to osteogenesis but not to 
chondrogenesis was shown early in 1961 by Bassett to be oxygen tension 
(Bassett et al. , 1961 ). He noted that high oxygen tension favors osteogenesis 
while chondrogenesis is favored by low oxygen tension in an in vitro culture · 
system (Jin et al., 2000). 
Another study by Kuboki showed that a high oxygen concentration was required 
for bone induction (Kuboki et al., 1995). Also findings by Tsuruga (Tsuruga et al., 
1997) and Kuboki (Kuboki et al., 1995) revealed that a scaffold geometry that 
restricted the vascular invasion would produce cartilage whereas geometries that 
could accommodate a haversian system would result in bone formation 
(Feinberg et al. , 2000). 
Reddi and Huggins were among the first to study the effect of the geometry of 
the cell substratum on cell differentiation and growth. They implanted two distinct 
particle sizes of decalcified bone powders containing BMP into rat skin, and 
found that more bone formation occurred in the coarse powder with a particle 
size of 420-850 µm than in the fine powder, sized 44-7 4 µm (Reddi e al., 1973). 
Lat_er, in 1984, Sam path and Reddi more clearly showed that coarse powder (7 4-
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420 µm) induced bone formation whereas powder of 44-7 4 ~Lm pore size did not. 
The study emphasized the crucial importance of the geometry of the scaffold in 
triggering the biochemical cascade of bone differentiation in vivo, however they 
did not touch upon the underlying mechanism (Sampath et al., 1984 ). 
In 1985, Shimazaki et al. compared the osteogenic ability of hydroxyapatite with 
pore sizes of 200-600 µm and 190-230 ~Lm and showed that hydroxyapatite with 
pore size of 200-600 µm resulted in more bone formation in the diaphyses of 
rabbit tibiae (Shimazaki et al., 1985). 
Another study examined osseous reactions in the rabbit femoral condyle to 
coralline hydroxyapatite bone substitutes of various pore sizes by radiology and 
histology. Results indicated that the pore size of the coralline hydroxyapatite 
influenced the development of bone in the implants in the cancellous bone bed of 
the rabbit femoral condyle. After 12 weeks in vivo scaffolds with a pore size of 
500 µm showed exter sive cellular and vascular invasion and new bone 
formation, while within 200 µm scaffolds there was no bone formation or cellular 
invasion (Kuhne et al., 1994 ). 
Contrary to the results of the study done by Shimazaki et al. another study 
reported that hydroxyapatite with pore sizes of 50-100 µm was superior to that of 
200-400 µm (Egg Ii et al., 1998). 
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A study done by Kuboki showed that rhBMP induced osteogenesis only when 
porous particles of HA were used as a carrier. In cases where fibrous glass 
membrane was used , only chondrogenesis occurred (Kuboki et al., 1995). As 
described above in detail, Tsuruga et al. illustrated that HA structures of 300-400 
µm pore size when complexed with rhBMP-2 were ideal for attachment, 
differentiation and growth of osteoblasts and for vascular ingrowth (Tsuruga et 
al., 1997). 
Gauthie r et al. , showed that macroporous (40% and 50% macroporosity) 
biphas ic calcium phosphate ceramics of a 563 µm pore size provided more new 
bone formation than a 300 µm pore size in both peripheral and deep pores. No 
significant differences were found between implants with 40% and 50% 
macroporosity , which suggests that the influence of macropore size was greater 
than that of ac . porosity percentage on bone ingrowth (Gauthier et al., 1998). 
90% porous 75:25 PLGA scaffolds cultured with neonatal rat calvarial 
osteoblasts were examined for the effects of cell seeding density , scaffold pore 
size , and foam thickness on the proliferation and function of cells in a 3-D 
environment. The data showed that over a 56-day period , comparable bone like 
tissues could be engineered using different cell densities of rat calvarial 
osteoblasts on biodegradable polymer scaffolds with a pore size in the range of 
150-710 µm. Comparing with the results of previous studies this investigation 
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demonstrates that PLGA foams are suitable substrates for osteoblast growth and 
differentiation function independent of cell source (lshaug-Riley et al. , 1998) . 
In 1999, Nam et al. conducted a study to fabricate macroporous biodegradable 
polymer scaffolds using gas foaming salt as a porogen additive. The study used 
highly porous biodegradable poly (L-lactic acid) [PLLA] scaffolds that were 
subjected to the method of fabrication. This resulted in the expansion of pores 
within the polymer matrix to a great extent, leading to well interconnected, 
macroporous scaffolds with a mean pore diameter of around 300-400 µm, which 
is ideal for high density cell seeding. Rat hepatocytes which were seeded into the 
scaffolds exhibited about 95% seeding efficiency and up to 40% viability one day 
after the seeding (Nam et al. , 1999). 
Fabrication 
There are several techniques to create highly porous scaffolds. Some of the 
ommonly used methodes include fiber bonding (Mikos et al., 1993a), solvent 
casting/particulate leaching (Mikos et al., 1993b ; Mikos et al., 1994), gas foaming 
(Mooney et al. , 1996a; N I e al., 20 ) and phase seperation (Lo et al., 1995; 
Whang et al., 1995; Lo et al., 1996; Schugens et al. , 1996; Nam & Park, 1999a; 
Nam & Park, 1999b). 
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Fiber bonding (unwoven mashes) technique produces highly porous PGA 
scaffolds with interconnected pores that are suitable for tissue generation using 
two different techniques (Freed et al., 1993; Mikos et al., 1993a; Mooney et al., 
1996b ). In the first technique , developed by Mikos et al. , PGA fibers are 
immersed in a PLLA solution , and following evaporation of solution, the network 
of PGA gets embedded in PLLA. The composite is then heated to above the 
melting temperature , which results in melting of PLLA, filling out all the voids left 
by the fibers while retaining the spatial arrangement of fibers. In order to 
minimize interfacial energy , fibers at the cross points become melted together 
forming highly porous foam. Then PLLA is removed by dissolution with 
methylene chloride. This technique results in foams with porosities as high as 
81 % and pore diameter of up to 500 µm (Mikos et al., 1993a). Study showed that 
hepatocytes cultured for one week in these foams remained alive and began 
interacting with each other to form cultures (Mikos et al., 1994). The second 
method of bonding PGA fiber uses atomization of PLLA or PLGA to coat the 
fibers. First PLLA or PLGA is dissolved in chloroform and sprayed onto the fibers 
of PGA. Fibers stay unchanged during this process since PGA is weakly soluble. 
Consequently solvent is evaporated, leaving the fibers glued with PLLA or PLGA. 
Porosities were not reported however pore sizes similar to those of previous 
techniques were achieved (Mooney et al., 1996b). Following implantation of tubes 
made in this manner in rats for 17 days, fibrous tissue ingrowth was seen , which 
indicates that constructs with these physical properties could encourage 
neotissue formation (Mooney et al. , 1996b). Both methods involve the use of 
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solvents that would be toxic to cells if not completely removed. To extract these 
chemicals, the constructs must be vacuum dried for several hours, which makes 
it difficult to use them immediately in a clinical setting. Furthermore, in the first 
method the composites are heated to extreme temperature. The high 
temperature combined with the effect of toxic chemicals presents difficulties if 
cells or bioactive molecules, such as growth factors, are to be incorporated into 
the fabrication (Mikos et al., 2000). 
Gas foaming technique involves using gas as a porogen to eliminate the need for 
the organic solvents in the process of making pores. The process uses solid 
disks of PGA, PLLA or PLGA made by compression molding with a heated mold. 
The disks are placed in a chamber and get exposed to high pressure CO2 (5.5 
Mpa) for three days , at which time the pressure is rapidly lowered to atmospheric 
pressure. Although this method of fabrication requires no leaching step and 
doesn't use harsh chemical solvents, the use of high temperature in making disks 
prohibits incorporation of cells or bioactive molecules and the unconnected pore 
structure make cell seeding and migration within the foam difficult (Mooney et al., 
1996a). Nam et al. developed another approach for using gas as a porogen. 
This technique includes both gas foaming and particulate leaching aspects. 
Ammonium bicarbonate is added to a solution polymer in chloroform or 
methylene chloride resulting in a highly viscous mixture that can be shaped by 
hand or with a mold. Solvent is evaporated and the composite is either vacuum 
dried or immersed in warm water. The immersion in water is the preferred 
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technique and it results in porosities as high as 90% with pore sizes from 200-
500 µm (Nam et al., 2000) . These foams were seeded with rat liver cells and up 
to 40% remained viable over one week in culture, which suggests that scaffolds 
are biocompatible and facilitate adequate nutrient exchange (Nam et al., 2000). 
However , the use of organic solvents and the long term effects of residues of 
ammonium bicarbonate on cells may put a stop to using these scaffolds in tissue 
engineering (Mikos et al. , 2000). 
Solvent casting/particulate leaching involves use of a water-soluble porogen such 
as salt (NaCl) to create pores . The porosity of the scaffolds can be controlled by 
the amount of salt added while the pore size is dependent on the size of the 
crystals. Foams fabricated by this technique have been extensively used with 
different cell types and no adverse effects on tissue formation have been 
observed. Pieces of the polymer/ salt composites are compression molded into 
cylindrical form t a temperature just above the melting (PLLA) or glass transition 
temperature (PLGA). This allows more precise control of scaffold thickness and 
also increases uniformity of the foam surface. The thermal degradation of the 
polymer during the compression-molding step could be a concern (Thomson et 
al. , 1998; Goldstein et al., 1999). The leaching step for water-soluble porogen 
significantly increases the preparation time of the scaffolds. However , where 
prefabrication of cell-polymer construct is suitable, promising results using a 
large range of cell types make these scaffolds very attractive (Mikos et al., 2000). 
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Phase separation/emulsification technique is based on the concept of phase 
separation rather than incorporation of a porogen. This includes 
emulsification/freeze drying (Whang et al., 1995) and liquid-liquid phase 
separation (Lo et al., 1995) . The use of organic solvents is a concern for the 
inclusion of cells and bioactive molecules. Even so, when using liquid-liquid 
phase separation, various parameters can be changed to tailor pore size and 
porosity for specific application, which is very favorable. However the phase 
diagrams of the polymer-solvent systems must be better characterized before 
fully exploiting this flexibility in tissue engineering constructs. (Mikos et al., 2000). 
Cell Seeding of the Scaffolds 
Cell based tis ue ... gineeri g invo! es seeding of cells onto a synthetic construct 
in vitro followed by transplantation of the construct. It is essential to optimize the 
cell seeding to successfully cultivate large tissue constructs. Seeding 
requirements for 3-D scaffolds include: 1) high yield, to maximize the utilization of 
donor cells, 2) high kinetic rate, to minimize the time in suspension culture for 
anchorage dependent and shear sensitive cells, and 3) spatially uniform 
distribution of attached cells, to provide a basis for tissue regeneration. Also, high 
initial construct cellularities are desirable to yield superior constructs (Vunjak-
Novakovic et al., 1998). 
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OBJECTIVE 
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Objective of the study 
According to the hypothesis the internal design of the scaffolds play a major role 
in the cell seeding and cell distribution . The objective of this study was to 
investigate the role of 3-D scaffold geometry and pilot its effect on the depth of 
distribution of cells. 
The experiments aimed at this objective were designed for: 
1- Isolation of osteoblast-like cells 
2- Design of the porous channeled and non-channeled scaffolds 
3- Fabrication of the channeled and non-channeled porous scaffolds 
composed of PLGA/BIE 
4- Examination of the effect of the 3-D scaffold geometry on cell distribution 
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Materials and Methods 
Materials: 
Material Manufacturer Lot Number Area Formula 
Ethyl Alcohol USP Aaper Alcohol 98L09QA Shelbyville N/A 
Absolute-200 Proof & Chemical Co. , KY 
Dulbecco 's modified Life Technology 10255584 Rockville, N/A 
eagle medium (DMEM) MD 
Minimum essential Life Technology 1022525 Rockville, N/A 
medium alpha medium MD 
(MEM) 
F-12 Nutrient Mixture Life Technology 1022007 Rockville, NIA 
(HAM) MD 
Fetal Bovine Serum Sigma 77H8418 St. Louis, N/A 
(FBS) MO 
Fungizone®, Lyophilized Life Technology 1027538 Rockville, N/A 
MD 
Menadio n ( 'itamin K3;2- Sigma 18H0300 St. Louis, N/A 
methyl-1,4 MO 
naphthoquinone) 
Penicillin-Stereptomycin Mediatech 1014761 Grand N/A 
Island , NY 
Calcium Chloride Sigma 83H086116 St. Louis, CaCb.2H2O 
MO (FW147.0) 
Chondroitine Sulfate Sigma 55H0306 St. Louis, 
MO 
1 a, 25- Sigma 98H0507 St. Louis, C27H44O3 
Dihydroxycholecalciferol MO (FW416.6) 
(1 a, 25-
Dihydroxyvitamin 03; 
Calcitriol) 
Alkaline phosphatase Sigma 098H6106 St. Louis, N/A 
245-10 Diagnostics MO 
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Collagenase , Lyophilized Life Technology 1021473 Rockville , N/A 
MD 
D-sorbitol Sigma 036H0065 St. Louis, 
MO 
Elastase Sigma 016H8045 St. Louis, N/A 
MO 
Hydrochloric Acid (Assay Sigma 83H3425 St. Louis , HCI (FW 
37.7%) MO 36.46) 
L-Ascorbic Acid Sigma 115H02865 St. Louis, CeHeOe (FW 
MO 176.1) 
Formalin Solution 10% Sigma 018H4378 St. Louis , 
Neutral Buffered Diagnostics MO 
Trypsin Life Tech no logy 1010374 Rockville, N/A 
MD 
Bioglass (Particle size: us Batch # Alachua, 
75-150 µm) Biomaterials CE0044 FL 
Corporation 
PLGA [85/': 5 Poly (DL- Birmingham Batch # Birmingha 
lactic-co -g lycolide) ] Polymers , Inc D99006 m,AL 
Neutral Red Sigma N-4270 St. Louis, N/A 
MO 
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Equipment: 
Item Manufacturer Model Area Description 
No. 
Gram-ATIC E-Mettler 1-90 Switzerland/Hei Balance 
Balance Zurich/Fisher ght , NJ 
Scientific 
Mettler PM Delta Range® PM 480 Height, NJ Balance 
480 
Cetric 1M Fisher 225 Height, NJ , Centrifuge 
Centrifuge Scientific 
Easy Pure RF Barn Stead 07031 Dubuque , IA Water purifier 
Compact 
Ultrapure 
Water System 
Nylon , 0.02 Fisherbrand Pittsburgh , PA Filter, Sterilize 
and 0.45 mm 
Filters 
Spectral Wallace Inc. All 1219 Gaithersburg, Gamma 
Liquid MD Counter 
Scintillation 
Precision Precision 5EM Winchester , VA Incubator 
Economy Scientific 
Incubator 
Water- Forma 3158 Marjetta, OH Incubator 
Jacketed scientific Inc. 
Incubator 
DAS Leitz DMIL 090- Wetzlar, Microscope 
Mikroskop 131.002 Germany 
Accumet Fisher 01375 USA pH meter 
Metro (Accu-
PHast™ 
Scientific (69490) 
Combination 
Electrodes) 
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Gyrotory® New G2 Edison, NJ Shaker 
Shaker Brunswick 
Scientific CO. 
Inc. 
Spectronic® Spectronic 400114 Rochester, NY Spectrophotome 
20 Genesys Instruments ter 
Corning 75 Corning Costa 430641 Cambridge, MA Tissue Culture 
cm2 Flask Corporation Treated, 0.2 mm 
vented cap, 
Polystyrene, 
Sterile, Non-
pyrogenic 
Costar 24 Well Corning 3524 Corning, NY Tissue Culture 
Cell Culture Incorporated Treated, 
Cluster 
4 
Polystyrene, 
Sterile, Non-
pyrogenic 
Touch Mixer Fisher 231 Height, NJ Vibrator 
Scientific 
SEM Philips XL20 Eindhoven, Microscope 
Netherlands 
Seives Fisher Height, NJ 
Scientific 
Dessicator Fisher Height, NJ 
Scientific 
Methods: 
Harvesting Osteoblasts 
This experiment involved using normal human osteoblast cells harvested from 
explantation of alveolar bone fragments from young adult patients. The donor 
~
patients were being treated at the Department of Oral and Maxillofacial Surgery 
of Boston University School of Dental Medicine and Boston Medical Center for 
removal of impacted third molars. All donors were in good general heath and 
were in the age range of 18-30 years old. The exclusion criteria were having any 
metabolic bone disease, taking any medication within the last 72 hours including 
any alcohol , smoking any substance, steroid use within the last 6 months, 
presence of an active infection , and any other medical disorders which may 
increase the risk of surgical complications. The impacted third molar extract ions 
were done under the standard anesthesia and incision techniques were 
performed, followed by removal of the alveolar bone. To attain sufficient number 
of osteoblasts for a single strain, bone tissue samples of 0.5-0.8 cm in diameter 
were collected if available. The bone chips were placed in serum-containing 
nutrient medium (DMEM/F-12 medium) containing 10% (v/v) antibiotics. The 
bone samples could be used for up to 24 hours later if kept cool at 4° C. 
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Human Osteoblast Cell culture 
The method used in this study was the Enzymatic Isolation method, modified 
from L. G. Rao et al. (1997), which causes a timed release of cells from the bone 
surface by using a bacterial collagenase-rich protease. This method has been 
used by P.G. Roby & J. D. Termine in 1985 on normal human bone obtained 
form patients during corrective surgery (Robey PG. & Termine JD., 1985). This 
procedure is based on the fact that bone cells cultured from bone explants will 
retain their osteoblastic properties on the subsequent cultures. Human 
osteoblasts maintain the phenotype through at least two passages (Erikson et al., 
1988; Harris SA, 1995). 
The procedure was performed in a sterile environment. Using bone cutters , the 
trabec ular bone fragments rvere exposed. Any clinging marrow was cleaned by 
washing with the nutrient medium. Explanted alveolar bone chips were scraped 
to remove any fibrous tissue. Using microdissecting scissors the bone fragments 
were minced into small pieces (2 mm in diameter). Bone chips were washed 
extensively with sterile Phosphate-Buffered Saline (PBS)/antibiotics (200 u/ml) to 
remove blood and marrow componenets. Then bone chips were digested twice 
with 5 ml enzyme cocktail for 15 minutes at 37° C in a shaking water bath. The 
enzyme cocktail was prepared with collagenase (3 mg/ml), elastase (6.25 U/ml), 
chondroitine sulfate (6 mg/ml), penicillin (100 U/ml), and D-sorbitol (18.22 mg/ml) 
in Kerb's buffer solution. Following enzymatic treatment, bony chips were 
washed with cold PBS, and cultured in a 25cm2 flask in culture medium. The 
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culture medium consists of phenol red-free DMEM/F12 (1: 1 ), 10% (v/v) heat 
inactivated Fetal Bovine Serum (FBS) with 200 IU/ml penicillin and 50 ug/ml 
Streptomycin/Fungizone. 
As a result of the collagenase treatment , osteoclasts and fibroblastic cells in the 
outer layer are released first followed by the release of osteoblasts in the inner 
layer (Sodek J & Berkman FA, 1987). The culture was maintained in an incubator 
at 37° C with 5% CO2 and saturated humidity. The culture medium was changed 
every day. The outgrowth of cells from bone fragments appeared within one 
week and these cells developed a confluent monolayer at 3-4 weeks. Once the 
pulpal expl : s d yielde suffi nt numbers of cells, they were transferred to 
bigger culture flasks and cultured until they reached confluence as described 
below. 
Bone chips were removed and the confluent cells were trypsinized by the 
addition of 5 ml of 0.25% trypsin solution. Within 5 minutes at 37° C, cells were 
detached when the medium was agitated. The trypsinized detached cells were 
mixed with an equa l volume of medium supplemented with 10% FBS to stop the 
trypsin activity. Then the cells were centrifuged at 1500 rpm for 5 minutes. 
Supernatant was discarded and the collected cell pellet was resuspended in 10-
20 ml of medium and plated in tissue culture dishes at 5 x 104 cells/dish (Sodek 
J& Berkman FA, 1987). This was done once the pulpal explants had yielded 
sufficient numbers of cells. They were transferred to bigger culture dishes and 
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cultured until they reached confluence. Experiments were performed using the 
cells subcultured at the end of the first passage (Robey PG & Termine JD, 1985; 
Sodek J & Berkman FA, 1987). 
Construction of Scaffolds 
Bone tissue engineering involves a 3-dimensional scaffold into which bone cells 
can be seeded to fabricate a 3-dimensional bone matrix. The degradable 
polymers used in this study allow room for tissue growth while eliminating the 
need for a second surgery (Temenoff & Mikos, 2000). In designing a substrate to 
be used in tissue engineering certain physical characteristics of the scaffold 
should be taken into consideration in addition to degradation rate. To promote 
cell growth, it is essencial for a scaffold to h~ve a large surface area to allow cell 
attachment. This can be achieved by creatir)g a highly porous scaffold . The size 
of the pores must be large enough so the cells can penetrate through them, and 
also the pores should be interconnected to allow for exchange of waste and 
nutrients by cells deep within the structure (Temenoff et al., in press). The 
method of fabrication plays an important roie in characteristics such as porosity 
and pore size (Mikos et al., 1993a; Mikos et al., 1994; Mooney et al., 1996a; Nam 
& Park, 1999b; Nam et al., 2000). 
Several methods have been developed to create highly porous scaffolds. The 
preferred technique used in this study is melt molding/particulate leaching (Mikos 
et al., 1993b; Mikos et al., 1994 ). Partic1e size of the polymers affects the 
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biosolubility and cell attachment. To create a porous scaffold a water-soluble 
porogen, salt (NaCl), was used (Mikos et al., 1993b, Mikos et al., 1994). To 
design scaffolds in this study, synthetic polymer, PLGA, with a particle size of 75-
250 µm was used to provide mechanical strength, Bioactive Inorganic Element 
(BIE) with a particle size of 75-150 µm was included to stimulate osteogenesis 
and salt (NaCl) with a particle size of 125-180 µm was used to create pores. 
Two groups of channeled and non-channeled scaffolds were fabricated by melt 
molding/particulate leaching. 
The melt molding/particulate leaching method involves using a water-soluble 
porogen, salt (NaCl), to create pores (Mikos et al., 1993b; Mikos et al., 1994). 
The scaffolds porosity can be controlled by the amount of salt added, while the 
size of the salt crystals determines the pore size. In this technique PLGA, BIE 
and salt were mixed to achieve scaffolds of 65% porosity. After mixing the 
mixture thoroughly, it was packed into Teflon molds and compression molded 
into cylindrical form. Teflon molds were designed to make cylindrical scaffolds of 
10 mm in width and 12 mm in length. The temperature setting should be just 
above the melting or glass transition temperature, and the thermal degradation of 
the polymer during the compression-molding step should be taken into 
consideration (Thomson et al., 1998; Goldstein et al., 1999). 
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Internal design of channeled scaffolds 
The channeled scaffolds had the same polymeric components and structure as 
the non-channeled group with the addition of seven channels. The channels were 
made by designing Teflon molds with six peripheral pins and one central pin. 
The steel pins are 0.8 mm in diameter and were nickel coated to reduce rusting. 
Each peripheral pin was located 2.5 mm from the border of the scaffold 
circumferentially , 2 mm from the adjacent pin and 2.5 mm from the central pin. 
After the casting of scaffolds the . pins were removed to create the channels , 
which run through the scaffold. 
2.0 mm 
2.5 mm 
0.8mm 
Fig. 1- Internal design of channeled scaffolds 
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Design of Experiment 
In This experiment 3 channeled and 3 non-channeled scaffolds were involved : 
7 channels No channel 
3 3 
Table 2- Design of experiment 
Fabrication of Scaffolds 
As described above two groups of channeled and non-channeled PLGA/BIE 
scaffolds of 65% porosity were fabricated . After the raw materials were placed in 
the molds , they were heated at 40° C/min ramping temperature, and held at 
180°C for 20 minutes, before cooling in the oven to 70° C. After the scaffolds 
were take out of e oven t ey were allowed to cool down to room temperature . 
The scaffolds were taken out of the Teflon molds and were prepared for leaching 
out of the salt particles. To leach out the salt particles the scaffolds were placed 
in sterile tubes containing distilled water and agitated on the shaker for 15 
minutes. At the end of 15 minutes the water was changed, fresh distilled water 
was gently added to the tube and the process was repeated. This process was 
repeated in four intervals of 15 minutes to allow complete leaching out of the salt 
particles. At the end of the fourth cycle the scaffolds were taken out of the tubes 
and were placed in fresh sterile tubes under negative pressure to get dried. 
During these processes the scaffolds had to be handled with extreme care since 
they were extremely fragile. 
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Measurement of Depth of Penetration of Osteoblasts 
Neutral Red Staining 
Borenfreund and Puener originally developed the Neutral Red assay system 
(Borenfreund et al., 1985). This technique is simple and accurate and yields 
reproducible results. The viable cells take up the dye, (Neutral Red), by active 
transport and will incorporate the dye into the lysosomes. This procedure uses 
0.33% Neutral Red solution [N-2889] in an amount equal to 10% of the culture 
medium volume. Cells in each flask were stained with this solution and were 
incubated for two hours. ter all ing the cells to incorporate the dye, they were 
briefly fixed with Neutral Red Assay Fixative [N-4270]. The fixative was removed, 
and the dye was solubilized in the solubilization solution. 
The stained cells were trypsinized by the addition of 5 ml of 0.25% trypsin 
solution. Cells were detached within 5 minutes by shaking at 37°C. The 
trypsinized detached cells were mixed with an equal volume of medium 
supplemented with 10% FBS to stop the trypsin activity. Then the cells were 
centrifuged at 1500 rpm for 5 minutes. Supernatant was discarded and the 
collected cell pellet was resuspended in 10 ml of medium. The cells were then 
ready to be seeded on scaffolds. 
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Cell Seeding of the Scaffolds 
The dynamic seeding technique was used in this experiment. Each scaffold 
(channeled and non-channeled) was placed into one tube containing the culture 
medium and collected cell pellet. The scaffolds were kept in this solution for 24 
hours under incubation conditions. After 24 hours the scaffolds were removed 
from their respective environment. 
The cell seeded scaffolds were fixed with formaldehyde and were embedded in 
paraffin and subsequently sectioned into sections of 1.5 mm. The sections were 
studied under the light microscope to explore the depth of the distribution of the 
Neutral-Red stained osteoblasts and to compare this value between the two 
groups of channeled and non-channeled scaffolds. 
Examination of sections of cell seeded scaffolds 
The cell-seeded scaffolds were studied in two groups of channeled and non-
channeled scaffolds each including three scaffolds. 24 hours after the cell 
seeding, scaffolds were fixed with formaldehyde and were paraffin embedded. 
Three sections were made from different areas of each scaffold. Sections were 
made using #15 surgical blade and were 1.5 mm in thickness. Prepared sections 
were studied under the light microscope and were investigated for the distribution 
of stained cells. 
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The depth of distribution of cells in each section was measured form the 
periphery of each section to the center. These measurements were taken from 
three different areas of each section in order to increase the accuracy, and a 
mean measurement was calculated. The values of depth of cell distribution for 
the three sections of each scaffold were used to determine the mean value for 
the depth of distribution of stained cells from the periphery to the center of each 
scaffold. Mean value was achieved for the depth of distribution of cells in the 
channeled scaffolds, versus the non-channeled scaffolds. These values were 
compared to investigate the role of internal geometry of the scaffolds in the depth 
of the cell distribution. 
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Results 
Fabrication of scaffolds 
There has not been any previous study on the incorporation of channels in the 
internal design of the scaffold. The first objective of this study was to fabricate 
channels into scaffolds. The scaffolds were fabricatedby melt molding/particulate 
leaching. This temperature setting during melt molding process was ideal for the 
fabrication of scaffolds since the temperature was just above the melting or glass 
transition temperature, and the thermal degradation of the polymer during the 
compression-molding step was also taken into consideration. If the temperature 
·were set too high, or too low it would result in the melting of particles or no effect 
in particles respectively. After the fabrication, the scaffolds were cooled down at 
room temperature and were taken out of their molds. The salt particles were 
leached out as discussed previously and the scaffolds were dried and kept in 
sterile tubes in a vacuum dessicator conditidn. 
One of the major concerns in fabrication df scaffolds was even distribution of 
their components. PLGA/BIE and salt should be thoroughly mixed so the result 
would be a uniformly porous scaffold. Scaffolds whose components were not 
! 
evenly mixed collapsed after the leaching of, the salt. This was due to dissolution 
of salt particles from non-evenly mixed components during the leaching process, 
resulting in big porous areas in the middle, _ends, or sides of the scaffolds. This 
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point became more of a concern in design and fabrication of channeled scaffolds. 
Many criteria were taken into consideration during the design of size of the 
channels, as well as the distance of channels from each other. This included the 
ideal pore size and the ideal particle size that would allow fabrication of channels 
without disturbing the integrity of the scaffolds. 
Channeled and non-channeled scaffolds were fabricated as previously explained. 
Special attention was given during the process of leaching out of the salt 
particles. At this stage, the scaffolds were extremely fragile and sensitive in need 
of extra care during handling. Once the scaffolds were dried out, they were kept 
in sterile tubes under negative pressure. Then the scaffolds were ready to be 
examined under a Scanning Electron Microscope (SEM). 
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Fig. 2- Non-channeled scaffold 
Fig. 3- Channeled Scaffold 
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Scanning Electron Microscopy 
Scaffolds were examined by Scanning Electron Microscopy (SEM) to evaluate 
the internal structure of the scaffolds. The SEM revealed the porosities and 
details in the internal design of scaffolds. Photographs of the mixture of 
PLGA/BIE and salt particles were taken during fabrication. We also took pictures 
of channeled and non-channeled examples before and after leaching out the salt 
particles. The integrity of each scaffold was maintained after leaching out. In the 
channeled scaffolds, the channels could be seen inside the porous structure of 
the scaffold. 
Fig. 4- Mixture of PLGA/Bioglass and salt particles during 
fabrication (SEM 1 000x) 
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Fig. 5- Non-channeled scaffold (SEM 1 Ox) 
Fig. 6- Internal structure of channeled scaffold before leaching out the 
salt particles. The salt particles are visible in this figure (SEM 200x). 
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Fig. 7- Internal structure of channeled scaffold after leaching out the 
salt particles (SEM 50x) 
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Preparation of Cell Seeded Scaffolds 
Cultures of normal adult human osteoblast-like cells were established. As 
previously described the cells were derived from explantation of alveolar bone of 
healthy adult patients harvested during surgical removal of third molars. Six cell 
strains were successfully achieved at the end of the first passage. The cells were 
trypsinized and were transferred to bigger flasks to undergo second passage and 
reach confluency. At the end of the second passage, cells were stained with 
Neutral Red, trypsinized, and dynamically cell-seeded on prepared scaffolds. 
After 24 hours, the samples were ready for further investigation. Following 
paraffin embedding of the scaffolds , they were sliced into sections of 1.5 mm 
· thickness. The sections were studied under a light microscope to study the depth 
of distribution of stained osteoblast cells in scaffolds. The two groups of scaffolds 
were compared for the depth of diffusion of cells from the periphery of scaffolds 
to the center as described previously. 
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Depth of Distribution 
Staining of the cells with Neutral Red allowed them to become visible under light 
microscopy, making it possible to follow the path of distribution and movement of 
cells in the scaffolds. As discussed previously the aim of the study was to 
investigate the role of the internal geometry of the scaffolds in expediting and 
facilitating the penetration of cells. Channels were incorporated in the design of 
scaffolds to advance cell distribution by providing portals of entry for the cells and 
culture medium. 
The outcome of the study was judged using sections of each scaffold prepared 
as discussed previously. Three sections of each scaffold were prepared, and the 
sections were studied under the microscope for the maximum depth of 
distribution of cells. T, ese three sections were selected from different areas of 
each cylindrical scaffold (top, center, and bottom) to allow more accurate overall 
measurements. Three measurements of the depth of distribution of cells were 
taken for each section, and a mean number was achieved for each scaffold. 
Using different sections of each scaffold, and measuring the maximum depth of 
distribution from three different areas of each section increased the accuracy of 
the experiment. The two mean values were compared in a two-sided t-test for the 
maximum depth of distribution of osteoblast cells between two groups. 
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- Channeled Scaffold #1 
Channeled Scaffold #1 Depth of distribution Mean Depth of distribution 
Section 1 4.0 4.5 3.5 4.0 
Section 2 5.0 5.0 5.0 5.0 
Section 3 4.0 5.0 4.5 4.5 
Table 3- Depth of distribution of cells in channeled scaffold #1 
Channeled Scaffold #1 
Mean Depth of distribution 14.50 
Table 4- Mean depth of distribution of cells in channeled 
scaffold #1 
- Channeled Scaffold #2 
Channeled Scaffold #2 Depth of distribution Mean Depth of distribution 
Section 1 4.0 5.0 3.0 4.0 
Section 2 4.0 4.5 5.0 4.5 
Section 3 3.0 3.5 4.0 3.5 
Table 5- Depth of distribution of cells in channeled scaffold# 2 
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Channeled Scaffold #2 
Mean Depth of distribution 14. 0 
Table 6- Mean depth of distribution of cells in channeled 
scaffold# 2 
- Channeled Scaffold #3 
Channeled Scaffold # 3 Depth of distribution Mean Depth of distribution 
Section 1 5.0 5.0 5.0 5.0 
Section 2 5.0 4.0 4.5 4.5 
Section 3 4.5 4.0 5.0 4.5 
Table 7- Depth of distribution of cells in channeled scaffold# 2 
Channeled Scaffold # 3 
Mean Depth of distribution J 4 .67 
Table 8- Mean depth of distribution of cells in channeled 
scaffold# 3 
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- Non-Channeled Scaffold #1 
Non-Channeled Scaffold # 1 Depth of distribution Mean Depth of distribution 
Section 1 1.00. 1.25 0.75 1.00 
Section 2 1.00 1.50 1.25 1.25 
Section 3 1.00 0.50 0.75 0.75 
Table 9- Depth of distribution of cells in non-channeled scaffold# 2 
Non-Channeled Scaffold # 1 
Mean Depth of distribution 11.00 
Table 10- Mean depth of distribution of cells in non-channeled 
scaffold# 1 
- Non-Channeled Scaffold #2 
Non-Channeled Scaffold # 2 Depth of distribution Mean Depth of distribution 
Section 1 1.25 1.75 0.75 1.25 
Section 2 0.50 1.00 0.75 0.75 
Section 3 1.00 1.50 1.25 1.25 
Table 11- Depth of distribution of cells in non-channeled scaffold# 2 
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Non-Channeled Scaffold #2 
Mean Depth of distribution 11.08 
Table 12- Mean depth of distribution of cells in non-channeled 
scaffold# 2 
-Non-Chan neled Scaffold #3 
Non-Channeled Scaffold # 3 Depth of distribution M~an Depth of distribution 
Section 1 1.00 1.50 2.00 1.50 
Section 2 1.25 1.50 1.75 1.50 
Section 3 1.00 1.25 1.50 1.25 
Table 13- Depth of distribution of cells in non-channeled scaffo ld# 3 
Non-Channeled Scaffold # 3 
Mean Depth of distribution 11.42 
Table 14- Mean depth of distribution of cells in non-channeled 
scaffold# 3 
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Channeled Mean Standard Group Group 
Scaffolds Deviation (SD) Mean SD 
Scaffold #1 4.5 0.50 4.39 0.49 
Scaffold #2 4.0 0.50 
Scaffold #3 4.67 0.29 
Table 15- Mean and standard deviation of the depth of distribution of cells 
in channeled scaffolds 
Non-Channeled Mean Standard Group Group 
-Scaffolds Deviation (SD) Mean SD 
Scaffold #1 1.0 0.25 1.17 0.28 
-Scaffold #2 1.08 0.2 
Scaffold #3 1.42 0.14 
Table 16- Mean and standard deviation of the depth of distribution of cells 
in non-channeled scaffolds 
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Graph 2- Mean values of depth of distribution of cells in all channeled versus 
all non-channeled scaffolds 
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The sections prepared from channeled scaffolds consistently showed more 
distribution of cells towards the center. As seen in the tables 15& 16 the data is 
statistically significant at _p-value of 7x10 -a_ The sections _ showed staining 
scattered unevenly on different areas of each section, some being more intensely 
stained than others. The stained cells were more abundant on the periphery and 
around the channels. High cell density around the location of channels showed 
their role in providing access for cells and culture media to enter and 
communicate through the body of the scaffold while providing a path for the 
nutritious materials into the scaffolds. 
In sections made of non-channeled scaffolds , the stained cells were mostly seen 
in the periphery. The maximum depth of distribution of cells did not exceed 1.75 
to 2 mm from the periphery. None of the sections showed distribution of cells to 
the center. The intensity of staining was higher around the borders and the 
staining became scattered and absent as one moves into the scaffolds centrally. 
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Fig. 8-Section of the channeled scaffold (original magnification x 40) 
Fig. 9- Section of non-channeled scaffold. Note that the stained cells 
can be seen mainly in periphery (original magnification x 40) 
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Fig. 10- Section of the channeled scaffold, showing the intensity 
around the two peripheral and the central channel ( original 
magnification x 40) 
Fig. 11-Section of non-channeled scaffold (original magnification x 40) 
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Discussion 
The newly-emerging field of tissue engineering uses tissue-specific cells in a 
three-dimensional organization, provided by a scaffolding material, to return 
functionality of the organ. Tissue engineering should solve the design and 
preparation of molecular scaffold , tissue vascularization , and dynamic culture of 
cells on the scaffolds in vitro. The choice of scaffolding material is critical to the 
success of the technique for these applications. In addition to the chemical 
properties of the material, physical properties such as surface area for cell 
attachment are essential. This experiment was conducted to investigate the 
effect of the internal geometry of the scaffolds, in the cell seeding of these 3-D 
structures by designing channels in their internal structure. We used human 
osteoblast cells unlike many other studies that used osteosarcoma cell lines such 
as MG63 (Price et al., 1997), or ROS 17/2.8 (Kaufman et al., 2000b), or 
extracted osteoblasts from animals (Loty et al., 2001 ). Normal human osteoblast 
cell lines were established and cultured in culture medium and. cell seeded on the 
prepared scaffolds. 
Scaffolds and biomaterials perform a crucial role in tissue engineering by guiding 
new tissue growth in vivo and in vitro. Numerous studies show extensive use of 
macroporous scaffolds composed of biodegradable polymers as three-
dimensional substrates either for in vitro cell seeding followed by transplantation, 
or as conductive substrates for direct implantation in vivo. The scaffolds must 
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functionally and molecularly integrate the neo-tissue with the surrounding host 
tissue. Scaffolds provide the reparative cells or their progenitors and the specific 
attachment or binding sites for endogenous reparative cells. The scaffolds must 
provide the signal to start the reparative process, the means and signals to 
expand the reparative cells, and also the space for the unique and oriented 
specialized ECM. Lastly, the scaffold should provide the capacity to functionally 
integrate this neo-tissue in a seamless manner with the host tissue. Adaptation of 
the present surgical materials has satisfied some demands in the field, however 
new applications need better control of depth of distribution of cells in the 
scaffolds. 
In this experiment we fabricated highly porous artificial extracellular matrix to 
provide accommodation for the cells and to direct their growth and tissue 
regeneration in three dimensions. Cell distribution is greatly affected by the size 
of the pores and overa rr poros ity of the scaffofd. Porous scaffo(cfs were fabr fcafecf 
by utilizing a solid porogen, salt (NaCl), with a particle size of 125-180 µm, to 
create pores in design of three-dimensional polymer matrix by melt 
molding/particulate leaching technique. Followi g leaching out the salt particles , 
a well-defined pore size and pore structure as well as a desired 65% scaffold 
porosity was achieved. 
The existing three-dimensional porous scaffolds for tissue engineering have 
proved less than perfect for actual application. Not only because they require 
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mechanical strength, but they also do not guarantee interconnected pores 
allowing maximum movements of cells and nutrients. Previous investigation has 
shown that mineralized bone and osteoid were found mostly at the periphery of 
the scaffold. The lack of tissue formation within the center of the scaffold could 
be due to inadequate cell penetration into the scaffold with a small pore size or 
as a result of poor oxygen diffusion throughout the shell of the avascular bone 
lining the scaffold perimeter (Whang et al., 1998). To overcome this problem, 
unlike the previous studies done, channels (6 peripheral channels and one 
central channel) were designed in highly porous scaffolds to allow nutrient and 
oxygen supply and high cell distribution into scaffolds. Channels allow 
maximizing depth of penetration of cells while optimizing the cell distribution, 
which is imperative in tissue engineering. 
The choice of the materials used in fabrication of scaffolds and their particle size 
affects osteogenesis. In this experiment, synthetic polymer, PLGA with a particle 
size of 75-250 µm was used to provide mechanical strength, and Bioactive 
Inorganic Element (BIE) with a particle size of 75-150 µm was included to 
stimulate osteogenesis. An experiment was designed to fabricate two groups of 
channeled and non-channeled scaffolds of 65%porosity. Following the cell 
seeding of scaffolds the depth of distribution of cells was studied and compared 
between the two groups of scaffolds. 
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Effect of scaffolds on osteogenesis 
The choice of scaffolding material and the 3-D structure significantly impacts the 
outcome of the osteoblast trans plantation . This experiment concentrated on the 
importance of the tructural de igr of the biomaterial employed as scaffolding 
architecture , and emphasized on the internal des ign of scaffold to optimize 
structural and nutritional conditions. In designing scaffolds to specifically meet 
survival and replicatio n condi tions of the cellular composites , surface 
biocompatibility as well as structural biocompatibility was taken into conside ration 
(Wintermantel et al. , 1996). To design a scaffold that met the survival and 
structural elements , pores were designed to form a complex structure . The 
coherence of these elements established the mechanical properties , distribution 
of open porosity , and the order of cells that utilize this superstructure as a 
scaffold. 
Bone tissue engineering uses different natural and synthetic materials in 
fabricating scaffolds. The choice of materials used in fabrication of scaffolds in 
this study was mainly based on biocompatibility , biodegradation , mechanical 
strength , bioactivity and the morphology of the scaffold . A major design problem 
was satisfying each of these requirements with a single scaffolding material 
(Murphy et al. , 2000). Materials were selected which promote bone formation, 
and provide porosity while still maintaining the structural integrity of the scaffolds. 
In this experiment PLGA , a synthetic polymer , was used to provide mechanical 
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strength, Bioactive Inorganic Element (BIE) was included to stimulate 
osteogenesis and salt was used to create pores. 
There are numerous in vivo studies that prove the role of Bioactive glass in 
osteoproduction. In 1998, Froum et al. conducted a comprehensive study using 
bioactive glass particles and compared them with open debridement in 59 
defects of 16 patients at 3, 6, and 9 months periods. Results showed that clinical 
attachment level was highly improved (p=0;0004) in Bioactive glass sites (2.96 
mm) compared with control sites (1.54 mm). Also, gingival recession was 
significantly less in these sites (1.29 mm) compared to control sites (1.87 mm). 
Bioactive glass sites showed significantly higher defect fill and depth reduction 
I (3.28 mm, 4.36 mm) compared with control areas (1 .45 mm, 3.15 mm) (Froum et 
al. 1998). There are many other studies that confirm this result and show the 
affect of Bioactive glass in osteogenesis (Wilson et al., 1992; Vrouwenvelder et 
al., 1994; Oonishi et al., 1994; Heikkila et a1.:, 1995). 
Bioactive Inorganic Element (BIE) is a composite that possesses the same 
criteria as Bioglass in bone formation. Previous studies have shown that BIE 
content enhances the osteogenic activity of osteoblasts, and that the composition 
of BIE may influence its osteogenic activities. The bioactivity is due to a certain 
compositional range of BIE that contains Cap, SiO2, Na2O, and P2Os. High Na2O 
~nd Cao content, and high CaO: P2Os made the surface highly reactive when 
exposed to an aqueous medium such as boqy fluid (Jamali M., Thesis,). 
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Biodegradable polymers, such as poly (lactic acid) (PLA) and poly (lactic-
coglycolic acid) (PLGA), are attractive materials for tissue engineering because 
of their degradative and mechanical properties, which permit scaffolds to be 
tailored to the individual requirements of different tissues (Lieb et al., 2003) . 
PLGA is a member of the thermoplastic aliphatic poly (esters) family [which also 
includes poly (PLA) and poly (glycolide) (PGA)] and possesses many favorable 
properties such as good biocompatibility, biodegradability, and mechanical 
strength (Jain RA, 2000). 
Many studies have been conducted to impart improved pore interconnectivity to 
polymer scaffolds for tissue engineering by partially fusing the solid porogen 
together prior to creation of a continuous polymer matrix. In this experiment salt 
was used to create porosity. Salt is the most commonly employed particulate 
since it is easily available and very easy to handle (Murphy et al., 2002). 
Effect of porosity and particle size of the scaffolds 
Bone regeneration is based on the hypothesis that normal healthy progenitor 
cells, either recruited or transported to a wounded site , can eventually regenerate 
lost or damaged tissue. Studies reveal that both high porosity and permeability 
are important for a tissue-engineering scaffold. Porosity provides space for the 
cells to infiltrate the scaffolds and also allows ECM formation. On the other hand, 
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high permeability allows for the inflow of nutrients and the elusion of metabolic 
waste and biodegradation by-products (Agrawal et al., 2000). 
In designing these scaffolds the fact that changing the porosity or permeability of 
the scaffold had a significant affect on the degradation characteristics of scaffolds 
was taken into consideration. Low porosity and permeability scaffolds degrade 
quicker. The length and continuity of pores and the surrounding spaces control 
capillary penetration, and as a result, influence bone formation. Pores must be 
larger than the diameter of active capillaries, which can supply enough blood for 
bone formation. The development of a single capillary should permit osteon-like 
structure formation. Salt weight fraction, salt particle size, and processing 
temperature play an important role on porosity and pore size of the extruded 
conduits. Increasing the salt particle size increases the pore diameter but does 
not affect the porosity. The porosity and pore size increases with increasing salt 
weight fraction. High extrusion temperatures decrease the pore diameter without 
altering the porosity. Greater decrease in molecular weight was observed for 
conduits manufactured at higher temper atures (Widmer et al., 1998). The method 
of fabrication, the temperature, and the time that the scaffolds were heated in the 
oven and the cooling down temperature greatly affect the outcome. These facts 
were taken into the consideration in designing the technique of fabrication of 
scaffolds. Based on the findings from previous experiments scaffolds of 65% 
porosity were fabricated. In this experiment pores were designed in the size 
range of 125-180 µm and this was achieved by using this size salt particles. 
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The size of the particles plays an important role in promoting osteogenesis in 
scaffolds. Previous studies showed that coarse particles promote more bone 
formation . In this experiment PLGA particles were used in the size range of 75-
250 µm and the Bioactive Inorganic Element (BIE) particle sizes were used in the 
size range of 75-150 µm. Three-dimensional porous polymer scaffolds improve 
bone regeneratio n by generating and retaining a space that facilitates progenitor 
cell migration, proliferation , and differentiation. Initial step to test this possibility 
was take n by c i uring th osteogenic cells on scaffolds, which were fabricated 
from biodegradable polymers, and the development of bone on these scaffolds 
was evaluated. 
Role of channels in design of scaffolds 
As previously described , the important components for the artificial matrix in 
development of 3-D systems for tissue regeneration, are its microarchitecture 
and the materials used. In designing this microarchitecture both the mechanical 
and biological characteristics of porous scaffolds were taken into the 
consideration. Unfortunately, even if a scaffold possesses optimized 
characteristics , it still may be deficient in regenerating large defects in host 
tissue. This can be due to lack of a delivery system for growth factors , nutrients, 
and oxygen through the 3-D structure to increase the scaffolds efficacy and 
ability to regenerate large tissue masses . The main objective of this experiment 
was to investigate the importance of the internal structure of the 3-D systems in 
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facilitating transport of cells and/or nutrients by fabricating peripheral and central 
channels in porous scaffolds. 
The advanced sea~. Id systems were designed to arrange cells/tissues in an 
appropriate 3-0 configuration and present microarchitecture in an appropriate 
spatial and temporal fashion so that the individual cells would be able to 
penetrate through this structure . This oriented microarchitectural features were 
designed to facilitate penetration of cells and nutrients into the core of the 
scaffold . The results of this study revealed that in porous bioabsorbable polymer 
scaffolds with no channels the osteogenic activity is located mainly at the 
periphery of the scaffold and the scaffold core is devoid of any stained cells. In 
sections prepared from non-channeled scaffolds the stained bone cells were 
seen limited to the periphery. The mean depth of distribution of cells into the 
three non-channeled scaffolds was 1.0, 1.08, and 1.42 mm (Table-16). As seen 
in figures of non-channeled scaffolds of one cm in diameter no cell distribution 
was seen in the core of the scaffold and staining, which is the sign of presence of 
cells, is limited to about 1-1.5 mm from the margin of the scaffold (Fig. 9&11). 
This results in value of 1.17 mm for the mean depth of distribution of cells in non-
channeled scaffolds (Table 16 & Graph- 2). However, the sections prepared from 
channeled scaffolds showed very deep distribution of cells to the center of the 
scaffolds. Despite what seen in sections of non-channeled scaffolds , in 
channeled scaffolds the stained cells distributed throughout each sect ion and 
penetrated into the core of each section (Fig. 8& 10). Some areas of channeled 
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sections such as periphery of the scaffold, and the location of channels showed 
deeper staining. This is due to the fact that cells transported through these 
portals of entries. Sections of three channeled scaffolds showed mean depth of 
distribution of 4.56, 4.00, and 4.67 mm (Table15). The value for the mean depth 
of distribution of cells in channeled scaffolds was 4.39 mm, which was more than 
the mean value for non-channeled scaffolds of 1.17 mm (Table 16& Graph- 2). 
The results of this study illustrated the important role of internal geometry of the 
scaffold in facilitating the distribution of cells. Porosity is known to play an 
important role in provid ing , ygen --~nd vase lature and facilitating the distribution 
of cells. However, as the result of our study shows, porosity by itself is not 
adequate in allowing transportation of cells and nutrients to the core of the 
scaffold. The results showed that cells could travel only to about 1.0-1.5 mm from 
the periphery of the porous scaffold and another mean of transportation besides 
pores was necessary to achieve maximum distribution of cells and nutrients. This 
was accomplished by including channels in the internal design of scaffolds. 
The main objective in designing the additional internal structures, channels , was 
to maximize cell distribution and achieve vascular invasion and cellular 
attachment in vivo. Channels incorporate an additional nutrient and osteoblast-
inducing geometry into the scaffold, which is essential for osteogenesis. A 
structure that allows capillaries, nutrients and oxygen into its interior induces 
bone formation, whereas one that prevents such a distribution induces cartilage 
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formation. By incorporation of channels into scaffolds the mean depth of 
distribution of cells from periphery to the core of each section increased from 
1.17 mm to 4.39 mm, which is statistically significant (Graph- 2). Channels 
provided an additional mean of entry for cells and nutrients allowing their 
penetration and distribution through additional ports. This was clearly visible 
under microscope that areas of peripheral and central channels demonstrated 
denser staining, showing the transportation of cells through them. 
Quantification of scaffold structure-function relationships is critical for optimizing 
mechanical and biological performance. To achieve maximum affect in tissue 
engineering a thorough understanding and appreciation of this matter is 
important. In this study addition of channels into the internal structure of porous 
scaffold significantly increased the depth of distribution of cells from 1.17 mm to 
4.39 mm in scaffolds of one cm in iameter. This value was statistically 
significant and showed the impact of internal structure of 30-scaffolds on tissue 
engineering. 
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CONCLUSION 
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Conclusions 
1- Scaffolds of 65% porosity composed pf PLGA/BIE were fabricated by melt 
molding/particulate leaching technique. Channels can be incorporated into 
the internal design of the porous scaffolds. 
2- The mean value for the depth of distribution of cells from periphery to the 
center in channeled scaffolds was 4.39 mm, which was more than the 
mean value of 1.17 mm for the depth of distribution of cells in non-
channeled scaffolds. 
3- This in vitro study indicated that channeled scaffolds consistently showed 
more distribution of cells towards the center. The data is statistically 
significant at p-value of 7x10 ~. 
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FUTURE STUDY 
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Future Study 
This experiment involved . the multidisciplinary fields of cell . biology, mater ial 
science, and tissue engineering. Time allowed for this study permitted limited 
sample size. Future study should encompass a broader range of sample 
selection and expand sample size. In this study we evaluated the effect of 
internal geometry of scaffold in the cell seeding of porous composites of 
PLGA/BIE. Possible effect of channels was evaluated in facilitating the 
distribution of cells. ture ·mrk , hould foc Js on optimizing the application of the 
porous channeled scaffolds in bone tissue-engineering and also on the 
evaluating these 3-D structures in an in vivo model in a way that can be carried 
out reproducibly, economically, and on a large scale. 
97 
BIBLIOGRAPHY 
98 
Bibliography 
Agrawal CM, McKinney JS, Lanctot D, Athanasiou KA. Effects of fluid flow on the 
in vitro degradation kinetics of biodegradable scaffolds for tissue 
engineering. Biomaterials 2000; 21 (23): 2443-2452 
Alexander CM, Werb Z. Extracellular matrix degradation I cell biology of 
extracellular matrix, 2nd Ed, Plenum press, New York and London. 1991; 
Chap 8: 27 4-279 
Aufmkolk B, Hauschka PV, Schwartz ER. Characterization of human bone cells 
in culture. Calcified Tissue International 1985; 37: 228-235 
Bassett CAL, Hermann I. Influence of oxygen concentration and mechanical 
factors on differ~ntiation of connective tissues in vitro. Nature 1961; 
190:460-461 
Borenfreund E, Puerner J. Toxicity determined in vitro by morphological 
alterations and neutral red absorption . Toxicol. Lett. 1985; 24: 119-124 
Bostman OM. Absorbable implants for the fixation of fractures. J Bone Joint 
Surg. 1991; 73: 148-153 
Buckwalter JA, Glimcher MJ, Cooper RR, Recker R. Bone biology. I: Structure, 
blood supply , cells, matrix , and mineralization. Instructional course lecture 
1996a; 45: 371-386 
Calvert JW , Marra KG. Cook L, Kumta PN, Dimilla PA, Weiss LE. 
Characterization of plastic and reconstr tive surgery. Journal of 
Biomedical Materials Research 2000; 52(2): 279-284 
Camargo PM, Lekovie V , Weinlaender M, Klokkevold PR, Kenney EB, 
Dimitrijievic B, Nedic M, Jancovic S, Orsini M. Influence of bioactive glass 
on changes in alveolar process dimensions after exodontias. Oral 
Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 
2000; 90: 581-586 
Christenson RH. Biochemical markers of bone metabolism : An overview. Clinical 
Biochem. 1997; 30: 573-593 
Duruncan C, Brown PW. Calcium-deficient hydroxyapatite-PLGA composites: 
mechanical and micorstructural investigation. J. Biomed. Mater. Res. 
2000; 51: 726-734 
Ecarot-Charrier B et al. Mineralization in osteoblast cultures: a light and electron 
microscopic study. Bone1988; 9(3): 147-154 
99 
Eggli PS, Muller W, Schneck RK. Porous hydroxyapatite and tricalcium 
phosphate cylinders with two different pore size range implanted in the 
cancellous bone of rabbit. Clin. Orthop. 1988; 232: 127-138 
Eiselt P, Kim BS, Chacko B, Isenbe rg B, Peters MC, Greene KG, Roland WO, 
Loebsack AB, Burg KJ, Culberson C, Halberstadt CR, Holder WO , 
Mooney DJ. Develo pment of techniques aiding large-tissue engineering. 
Biotechnology progress 1998 ; 14: 134-140 
Ericksen EF, Clavar d OS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs 
BL. E i---ienc0 f.es tro en receptors in normal human osteoblast-like cells. 
Sc ...,nee 1988; 241 : 84-86 
Feinberg SE , Hollister SJ , Halloran JW , Gabe Chu TM, Krebsbach PH. A tissue 
engineering approach to site-specific reconstruction of skeletal structures 
of the Maxillofacial region: Part I. Shanghai Journal . of Stomatolgy 2000 ; 
9(1 ): 34-38 
Feinberg SE, Hollister SJ, Halloran JW , Gabe Chu TM, Krebsbach PH. A tissue 
engineering approach to site-specific reconstruction of skeletal structures 
of the Maxillofacial region: Part II . Shanghai Journal of Stomatolgy 2000 ; 
9(2): 88-93 
Filgueiras MR , Torre GL, Hench LL. Solution effects on the surface reactions of 
three bioactive glass. J. Biomed. Mater. Res. 1993a; 27: 445-453 
Filgueiras MR, Torre GL, Hench LL. Solution effects on the surface reactions of a 
Bioactive glass. J. Biomed. Mater. Res. 1993b; 27: 1485-1493 
Freed LE, Marquis JC , Nohria A , Emmanual J, Mikos AG , Langer R. 
Neocartilage formation in vitro and in vivo using cells cultured on synthetic 
biodegradable polymers. J Biomad Mater Res. 1993; 27: 11-23 
Freed LE, Hollander AP , Martin I, Barry JR , Langer R, Vunjak-Novakovic G. 
Chodrogenesis in a cell-polymer-bioreactor system. Experimental Cell 
Res. 1998;240 ~ 58-65 
Forum SJ, Weinberg MA, Tarnow D. Comparison of bioactive glass synthetic 
bone graft particles and open debridement in the treatment of human 
periodontal defects. A clinical study. J. Periodontal. 1998 ; 69: 698-709 
Fu K, Pacj OW, Klibanov AM, Langer R. Visual evidence of acidic environment 
within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. 
Pharmaceutical Research 2000; 17: 100-106 
100 
Gao J, Niklason L, Langer R. Surface hydrolysis of poly (glycolic acid) meshes 
increases the seeding density of vascular smooth muscle cells. J. Biomed. 
Mater. Res. 1998; 42 : 417-424 
Gauthier 0 , Bouler J, Aguado E, Pilet P, Daculsi G. Macroporous biphas ic 
calcium phosphate ceramics: influence of macropore diameter and 
macroporosity percentage on bone ingrowth. Biomaterials 1998; 19(1-3): 
133-139 
Gilding DK, Reed AM . Biodegradable polymers for use in surgery- Poly 
(glycolic)/Poly(lactic) acid homo-and copolumers: 1. Polymer 1981; 
20:1459-1464 
Goldstein AS , Zhu G, Morris GE, Meszlenyi RK, Mikos AG. Effect of osteoblastic 
culture conditions on the structure of poly (DL-lactic-co-glycolic acid) foam 
scaffolds. Tissue Eng. 1999; 5(5): 421-434 
Graham PD, Brodbeck KJ, McHugh AJ. Phase inversion dynamics of PLGA 
solutions related to drug delivery. J. Controlled Release. 1999; 58:233-245 
Greish YE, Brown PW. Characterization of bioactive glass-reinfo rced HAP 
polymer composites. J. Biomed. Mater. Res. 2000 ; 52: 687-694 
Harris SA, Enger RJ, Riggs BL, Spelsberg T. Development and characterization 
of a conditionally immortalized human fetal osteoblastic cell line. J. Bone 
Miner. Res. 1995; 10: 178-186 
Hauschka PV, Wians FH. Osteocalcin and matrix Gia protein: vitamin K-
dependent proteins in bone. Physiological Review 1989; 69: 990-1047 
Hay ED. Introductory remarks in cell biology of extracellular matrix, 2nd ed., 
Plenum Press, New York and London 1991; 1-4 
Heikkila JT, Aho HJ, Yli-Urpo A, Happonen RP, Aho AJ. Bone formation in rabbit 
cancellous bone defects filled with bioactive glass granules. Acta. Orhop. 
Scand. 1995; 66:463-467 
Hench LL. Bioactive ceramics: Theory and clinical applications. Bioceramics 
1994; 7: 3-14 
Hench LL. Bioactive glass and tissue regeneration. Bioceramics1996 ; 9: 3-6 
Hench LL. Bioceramics. J Am Ceramic Soc. 1998; 81 (7): 1705-1728 
Hollister SJ, Levy RA, Chu T, Halloran JW , Feinberg SE. A6 image-based 
101 
approach for designing and manufacturing craniofacial scaffolds. Int. J. 
Oral maxillofac. Surg. 2000; 29: 67-71 
Huffer W. Morphology and biochemistry of bone remodeling: possible control by 
vitamin D,· parathyroid hormone, and other substances. Lab, Invest. 1998; 
59: 418-442 
Hsu Y, Gresser JD, Trantolo DJ, Lyons CM, Gangadharam RJ, Wise DL. Effect 
of polymer foam morphology and density on kinetics of in vitro controlled 
release of isoniazid from compressed foam matrices. J. Biomed. Mater. 
Res. 1997; 35: 107-116 
lshaug SL, Yaszemski MJ, Bizios R, Mikos AG. Osteoblast function on synthetic 
biodegradable polymers. J. Biomed. Mater. Res. 1994; 28(12):1445-1453 
lshaug-Riley SL, Crane GM, Gurlek A, Miller MJ, Vasko AW , Yaszemski MJ, 
Mikos AG. Ectopic bone formation by marrow stromal osteoblast 
transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into 
the rat mesentery. J. Biomed. Mater. Res. 1997; 36: 1-8 
Jain RA. The manufacturing techniques of various drug loaded biodegradable 
poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475-
2490 
Jamali M, Chou L. Osteogenic material for bone tissue engineering. Thesis of 
Boston University 2001 
Jin Q-M, Takita H, Kohgo T, Atsumi K, ltoh H, Kuboki Y. Effects of geometry of 
hydroxyapatite as a cell substrum in BMP-induced ectopic bone formation. 
J. Biomed. Mater. Res. 2000; 52: 491-499 
Juni K, Nakano M. Poly(hydroxy acids) in drug delivery. Critical Reviews in 
Therapeutic Drug Carrier Systems 1987; 3: 209-232 
Kang H, Tabata Y, lkada Y. Fabrication of porous gelatin scaffolds for tissue 
engineering. Biomaterials 1999; 20: 1339-1344 
Kaufmann EA, Ducheyne P, Shapiro IM. Effect of varying physical properties of 
porous, surface modified bioactive glass 45S5 on osteoblast proliferation 
and maturation. J. Biomed. Mater. Res. 2000b; 52: 783-796 
Kokubo T. Ca, P-rich formed on high strength b)oactive glass-ceramic A-W. J. 
Biomed . Mater . Res. 1990a; 24: 331-~4 
Kuboki Y, Saito T, Murata M, Takita H, Mizuno M, Inoue M, Nagai N, Poole AR. 
Two distinctive BMP-Carriers induce zonal chondrogenesis and 
102 
membranous ossification, respectively; geometrical factors of matrices for 
cell-differentiation. Connective Tissue Research 1995; 32(1-4 ): 219-226 
Kostanski JW, Thanoo BC, Deluca PP. Preparation, characterization, and in vitro 
evaluation of 1- and 4-month controlled release orntid.e PLA and PLGA 
microspheres. Pharmaceutical Devel. Techno. 2000; 5: 585-596 
Kuhne J, Bartl R, Frisch B, Hammer C, Jansson V, Zimmer M. Bone formation in 
coralline hydroxyapatite. Acta Orthop. Scand. 1994; 65(3): 246-252 
Laurencin CT, Attawia MA, Elgendy HE, Herbert KM. Tissue engineered bone-
regeneration using degradable polymers: the formation of mineralized 
matrices. Bone 1996; 19: 935-995 
Lieb E, Tessmar J, Hacker M, Fischbach C, Rose D, Blunk T, Mikos AG, 
Gopferich A, Schulz MB . Poly(D,L-lactic acid)-Poly(ethylene glycol)-
Monomethyl Ether Diblock Copolymers Control Adhesion and Osteoblastic 
Differentiation of Marrow Stromal Cells . Tissue Eng. 2003; 9(1 ):71-84 
Lian JB, Coutts M, Canalis E. Properties and biosynthesis of a vitamin K-
dependent calcium binding prote in in bone. Federation Proceeding 1978; 
37: 2615-26 20 
Lindfors NC, Aho AJ. Tissue response to Bioactive glass and outogenous bone 
in the rabbit spine. European spine jou_rnal 2000; 9: 30-35 
Lo H, Ponticiello MS, Leong KW. Fabrication of controlled release biodegradable 
polymer foams by phase separation. Tissue Eng. 1995; 1: 15-28 
Lo H, Kadiyala S, Guggino SE, Leong KW. Poly(L-lactic acid) foams with cell 
seeding and controlled-release capacity. J. Biomed. Mater. Res. 1996; 30: 
475-484 
Loty C, Sautier JM, Tan MT, Oboeuf M, Jallot E, Boulekbache H, Greenspan D, 
Forest N. Bioactive glass stimulates in vitro osteoblast differentiation and 
creates a favorable template for bone tissue formation. J. Bone & Mineral 
Res. 2001; 16:231-239 
Low SB, King CJ, Kreiger J. An evaluation of bioactive ceramic in the treatment 
of periodontal osseous defects. Int. J. Perio. Recons. Dent. 1997; 17: 358-
367 
Lu L, Peter SJ, Lyman MD, Lai HL, Leite SM, Tamada JA, Vacanti JP, Langer R, 
Mikos AG. In vitro degradation of porous poly(L-lactic acid) foams. 
Biomaterials 2000; 21: 1595-1605 
103 
Marks SC Jr, Popoff SN. Bone cell biology: the regulation of development, 
structure, and function in the skeleton. Am. J. Anat. 1988; 183(1 ): 1-44 
Mikos AG , Lyman MD, Freed LE, Langer R. Wetting of poly(L-lactic acid) and 
poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994; 
15(1 ): 55-8 
Mikos AG, Sarakinos G, Leite SM, Vacanti JP, Langer R. Laminated three-
dimensional biodegradable foams for use in tissue engineering. 
Biomaterials 1993a; 14(5): 323-30 
Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP, Langer R. Preparation of 
poly(glycolic acid) bonded fiber structures for cell attachment and 
transplantation. J. Biomed. Mater. Res. 1993b; 27(2): 183-9 
Mikos AG, Temenoff JS. Formation of highly porous biodegradable scaffolds for 
tissue engineering. Electronic Journal of Biotechnology 2000 
Mooney DJ, Baldwin OF, Suh NP, Vacanti JP, Langer R. Novel approach to 
fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the 
use of organic solvents. Biomaterials 1996a; 17(14): 1417-1422 
Mooney DJ, mazzoni CL, Breuer C, Macnamara K, Hern D, Vacanti JP. 
Stabilized polyglycolic acid fiber-based tubes for tissue engineering. 
Biomaterials 1996b; 17: 115-124 
Murphy WL, Mooney DJ. Controlled delivery of inductive proteins , plasmid DNA 
and cells from tissue engineering matrices. Journal of Periodontal 
Research 1999; 34(7): 413-419 
Murphy WL, Dennis RG, Kileny JL, Mooney DJ. Salt fusion: an approach to 
improve pore interconnectivity within tissue engineering scaffolds. 
Tissue Eng. 2002; 8(1 ): 43-52 
Nam YS, Park TG. Biodegradable polymeric microcellular foams by modified 
thermally induced phase separation method. Biomaterials 1999a; 20: 
1783-1790 
Nam YS, Park TG. Porous biodegradable polymeric scaffolds prepared by 
thermally induced phase separation. J. Biomed. Mater. Res. 1999b; 4 7: 8-
17 ~ 
Nam YS, Yoon JJ, Park TG. A novel fabrication method of macroporous 
biodegradable polymer scaffolds using gas foaming salt as a porogen 
additive. J. Biomed. Mater . Res. 2000; 53: 1-7 
104 
Nijweide PJ, Burger EH, Feyen JH. Cells of bone: proliferation , differentiation , 
and hormonal regulation. Physiol. Rev. 1986; 66(4): 855-886 
Oonishi H, Kush itani S, Yasukawa E, lwaki H, Hench LL, Wilson J, Tsuji E, 
Sugihara T. Particulate Bioglass compared with hydroxyapatite as a bone 
graft substitute. Clinical Orthopedics 1997; 334: 316-325 
Oonishi H, Hench LL, Wilson J, Sugihara F, Tsuji E, Matsuura M, Kin S, 
Yamamoto T, Mizokawa S. Quantitative comparison of bone growth 
behavior in granules of bioglass , A-W glass-ceramic , and hydroxyapatite. 
J. Biomed . Mater. es 2000; 51: 37-46 
Owen TA , Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, 
Kennedy MB, Pockwinse S, Lian JB , Stein GS. Progressive development 
of the rat osteoblast phenotype in vitro: Reciprocal relationships in 
expression of genes associated with osteoblast proliferation and 
differentiation during formation of the bone extracellular matrix. J. Cell. 
Physiol. 1990; 143: 420-30 
Price N, Bendall SP, Frondoza C, Jinnah RH, Hungerford OS. Human osteoblast-
like cells (MG63) proliferate on a bioactive surface. J. Biomed. Mater. Res. 
1997; 37: 394-400 
Puelacher We, Mooney D, Langer R, Upton J, Vacanti JP, Vacanti CA. Design of 
nasoseptal cartilage replacement synthesized from biodegradable 
polymers and chondrocytes. Biomaterials 1994c; 15: 77 4-778 
Putnam AJ, Mooney DJ. Tissue engineering using synthetic extracellular 
matrices . Nat. Med. 1996; 2(7): 824-826 
Reddi AH , Huggins CB. Influence of geometry of transplanted tooth and bone on 
transformation of fibroblast. Proc. Soc. Exp. Biol. Med. 143: 4634-4637 
Roberts WE , Garetto LP. Physiology of osseous and fibrous integration. 
Scientific 1992; 85: 57-60 
Robey PG, Termine JD. Human bone cells in vitro. Calcif. Tissue Int. 1985; 37: 
453-460 
Rust KR, Singleton GT, Wilson J. Anthonelli PJ. Bioglass middle ear prosthesis: 
long-term results. Am._J~ Otology 1996; 17: 371-37 4 
Sampath TK, Reddi AH. Importance of geometry of the extracellular matrix in 
endochondral bone differentiation . J. Cell Biol. 1984; 98(6): 2192-2197 
105 
Shimazaki K, Mooney V. Comparative study of porous hydroxyapatite and 
tricalcium phosphate as bone substitute. J Orthop. Res. 3: 301-310 
Schrier JA, Deluca PP. Recombinant human bone morphogenic protein-2 binding 
and incorporation in PLGA microsphere delivery systems. Pharmaceutical 
Develop. Techno. 1999; 4: 611-621 
Schugens C, Maquet V, Grandfils C, Jerome R, Teyssie P. Polylactide 
macroporous biodegradable implants for cell transplantation 11. 
Preparation of polylactide foams for liquid-liquid phase separation . J. 
Biomed. Mater. Res. 1996; 30: 449-461 
Schulz RC. Bone defects and outogenous reconstruction. In: Schulz RC, editor . 
Facial injuries. Chicago: Year Book Med ical 1988; 564-601 
Shalhoub V. Glucocortico id promote development of the osteoblast phenotype by 
selectively modulating expression of cell growth and differentiation 
associated genes. J. Cell Biochem. 1992, 50: 425-440 
Sodek J & Berkman FA. Bone cell cultures. Methods in Enzymology 1987; 145: 
303-324 
Stanely HR, Hall MB, Clark AE , King CJ 3rd , Hench LL, Berte JJ. Using 45S5 
bioglass cones as endosseous ridge maintenance implant to prevent 
alveolar ridge resorption: a 5-year evaluation. Int. J. Oral. Maxillofac . 
Implants 1997; 12: 95-105 
Stein GS, Lian JB. Molecular mechanism mediating proliferation/differentiation 
interrelationships during progressive development of the osteoblast 
phenotype. Endocrine reviews 1993; 14: 424-442 
Stein GS, Lian JB. Transitional control of osteoblast growth and differentiation . 
Physiol. Rev. 1996; 76: 593-629 
Thomson RC, Yaszemski MJ, Powers JM. Fabrication of biodegradable polymer 
scaffolds to engineering trabecular bone. J. Biomater. Sci. Polym. Ed. 
1995; 7: 23-28 
Thomson BM et al. Type I collagen degradation by mouse calvaria osteoblasts 
stimulated with--4,25-dyhydroxyvitamin D3 : evidence for a plasminogen-
plasmin-metalloproteinase activation cascade. Biochemica et Biophysia 
ACTA 1989; 1014:125-132 
Tomford WM , Doppelt SH, Mankin HJ, Friedlander GE. Bone bank procedures. 
Clin. Orthop. Rel. Res. 1983; 17 4: 15-21 
106 
Tsuruga e, Takita H, ltoh H, Wakisaka Y, Kuboki Y. Pore size of porous 
hydroxyapatite as the cell-substratum controls BMP-lnduced 
osteogenesis. J. Biochem. 1997; 121: 317-324 
Vrouwenvelder WCA , Groot CG, Gtoot KD. Better histology and biochemistry for 
osteoblasts cultured on titanium-doped bioactive glass: Bioglass 45S5 
compared with iron- , titanium-, fluorine-, and boron-containing bioactive 
glasses. Biomateria ls 1994; 15: 97-106 
Vunjak-Novakovic G, Obradovic B, Martin I, Bursae PM, Langer R, Freed LE. 
Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. 
Biotechnol. Prog. 1998; 14(2): 193-202 
Webber WL, Lag F, Tha os C, Mathio itz E. Characterization of soluble , salt-
loaded, degradable PLGA films and their release of tetracycline. J 
Biomed . Mater. Res. 1998; 41: 18-29 
Whang K, Thomas CH, Healy KE. Fabrication of porous biodegradable scaffolds. 
Polymer 1995; 36: 837-845 
Wheeler DL, Stokes KE, Park HM, Holloinger JO. Evaluation of particulate 
Bioglass in rabbit radius ostectomy model. J. Biomed. Mat. Res. 1997; 35: 
249-254 
Widmer MS, Gupta PK, Lu L, Meszlenyi RK, Evans GR, Brandt K, Savel T, 
Gurlek A , Patrick CW Jr, Mikos AG. Manufacture of porous biodegradable 
polymer conduits by an extrusion process for guided tissue regeneration. 
Biomaterials 1998; 19(21): 1945-1955 
Wilson J. Toxicology and biocompatibility of Bioglasses. J. Biomed. Mat. Res . 
. 1981; 15: 805-817 
Wilson J & Low SB. Bioactive Ceramics for Periodontal Treatment: Comparative 
studies in the patus monkey . Journal of Applied Biomaterials 1992; 
3: 123-129 
Wilson J, Clark AE , Douek E, Krieger J, Smith WK, Zamet JS. Clinical 
applications of Bioglass implants. ih International symposium on ceramics 
in medicine 1994 
Wintermantel E, Mayer J, Blum J, Eckert KL, Luscher P, Mathey M. Tissue 
engineering scaffolds using superstructures. Biomaterials 1996; 17: 83-91 
Xynos ID, Hukkanen MY J, Batten JJ, Buterly LD, Hench LL, Polak JM. Bioglass 
107 
45S5 stimulates osteoblast turnover and enhances bone formation in vitro: 
implications and applications for bone tissue engineering. Calcified Tissue 
International 2000; 67: 321-329 
Yilmaz S, Efeoglu E, Kilic AR. Alveolar ridge reconstruction and/or preservation 
using root form bioglass cones. J. Clin. Perio. 1998; 25: 832-839 
Zhang L, Chu CC, Loh I. Effect of a combined gamma irradiation and parylene 
plasma treatment on hydrolytic degradation of synthetic biodegradable 
sutures . J. Biomed. Mater. Res. 1993; 27: 1425-1441 
Zhang L, Jin AM , Guo ZM, Min SX, Quan DP, Lu ZJ. Effect of pore size of D, L-
polylactic acid as bone repair material on bone regeneration . Di Yi Jun Yi 
Da Xue Xue Bao 2002 ; 22(5): 423-6 
108 
